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The aim of this study is to develop highly enantioselective isomerization 
reactions catalyzed by chiral bicyclic guanidines. 
A chiral bicyclic guanidine was found to catalyze the isomerization of alkynes to 
chiral allenes with high ees. The axial chirality was efficiently transferred to 
functionalized butenolides and cycloaddition products. We have also successfully 
demonstrated the stereospecific synthesis of butenolide through allenoate cyclization 
with a catalytic cationic Au(I) complex. A possible mechanism has been proposed to 
explain the enantioselective isomerization reaction.  
We have also found that a Brønsted-base catalyzed tandem isomerization-Michael 
reaction can be used to form useful heterocycles under mild conditions. This efficient 
method was applied to the synthesis of various functionalized 
2-alkylidenetetrahydrofurans with excellent yields. Tandem 
isomerization-aza-Michael reaction with alkynyl-amines, alkynyl-amide and 
alkynyl-carbamates led to interesting piperidines, lactams and oxazolidinones. 
Asymmetric version of tandem isomerization-aza-Michael reaction was tested to give 
moderate ee using a chiral bicyclic guanidine as a catalyst. 
 We have discovered a Brønsted-base catalyzed tandem Mannich-isomerization 
reaction between imines and itaconimides. Moderate to good ees were achieved with 
this reaction catalyzed by a chiral bicyclic guanidine.  
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Chiral Guanidines and Guanidinium 





1.1 Introduction to Guanidine Catalysts 
Guanidiniums and guanidines are presented in many natural products which are 
often found to have significant biological activities.1 Among the most remarkable 
guanidiniums are marine guanidine alkaloids such as crambescidins and ptilomycalin 
A (Figure 1.1) which display a variety of pharmacological activities. Many 
guanidiniums are also designed to function as anionic receptors.2 The guanidine side 
chain of Arginine 3 (Figure 1.1), which is found in the active site of many enzymes, 
typically exists in the protonated form as a guanidinium ion. The guanidinium ion is 
known to interact with phosphates, nucleotide bases, and carboxylate containing 
























ptilomycalin A: R1 = H, R2 = H, n = 1;




2 3  
Figure 1.1 Structures of natural products 2 ptilomycalin A, crambescidines, and 
L-arginine 3. 
 This special hydrogen bonding pattern of the guanidinium ion is also applied in 
                                                        
1 (a) Berlinck, R. G. S.; Kossuga, M. H. Nat. Prod. Rep. 2005, 22, 516–550. (b) Berlinck, R. G. S.; Burtoloso, A. C. 
B.; Kossuga, M. H.; Nat. Prod. Rep. 2008, 25, 919–954. 
2 For reviews on guanidium-based anionic receptors, see: (a) Best, M. D.; Tobey, S. L.; Anslyn, E. V. Coord. Chem. 
Rev. 2003, 240, 3–15. (b) Schng, K. A.; Lindner, W. Chem. Rev. 2005, 105, 67–113. (c) Blondeau, P.; Segura, M.; 
Fernández, R. P.; de Mendoza, J. Chem. Soc. Rev. 2007, 36, 198–210. 
3 (a) Bioorganic Chemistry Frontiers; Hannon, C. L., Anslyn, E. V., Ed.; Dugas, H.; Springer-Verlag, Berlin, 
Heidelberg, 1993, pp. 193–256. (b) The Chemistry of Amidines and Imidates, Vol 2.; Yamamoto, Y., Kojima, S., 
Eds.; Patai, S., Rappoport, Z.; John Wiley & Sons Inc., New York, 1991, pp. 485–526. 
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asymmetric synthesis using chiral guanidine catalysts.4 Neutral chiral guanidines are 
also widely used as strong bases in enantioselective reactions.5 Chiral guanidine 
catalysts are generally classified into five categories: acyclic guanidines with chiral 
side chains, mono-to-polycyclic guanidines, axial chiral guanidines, guanidium salts, 
and bifunctional guanidine catalysts.  
1.1 Acyclic Guanidines with Chiral Side Chains  
 
Scheme 1.1 Henry reaction catalyzed by homochiral guanidine. 
Nájera group reported one of the earliest chiral guanidine catalyzed 
enantioselective reactions on Henry reactions in 1994.6 The best enantioselectivity 
was achieved with C2-symmetrical guanidine 4, affording 7a in 54% ee and 7b in 
33% ee (Scheme 1.1, eq 1). Ma et al. studied the diastereoselective Henry reactions of 
N,N-dibenzyl α-amino aldehydes 9 with nitromethane 6 catalyzed by acyclic 
guanidines (Scheme 1.1, eq 2).7 Acyclic guanidine 8a was found to be the best 
catalyst to give 92% de value. However, the reaction was not general as de values 
                                                        
4 For extensive review on asymmetric catalysis using hydrogen bonding, see: Doyle, A. G.; Jacobsen, E. N. Chem. 
Rev. 2007, 107, 5713–5743. 
5 For review on application of guanidines in organic synthesis, see: (a) Ishikawa, T.; Kumamoto, T. Synthesis 2006, 
737–752. (b) Leow, D.; Tan, C.-H. Chem. Asian. J. 2009, 4, 488–507. 
6 Chinchilla, R.; Nájera, C.; Sánchez-Agulló, P. Tetrahedron: Asymmetry 1994, 5, 1393–1402. 
7 Chinchilla, R.; Nájera, C.; Sánchez-Agulló, P. Tetrahedron: Asymmetry 1994, 5, 1393–1402. 
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range from 32-91% for other examples. 
 
Scheme 1.2 Lipton’s cyclic dipeptide catalyzed Strecker reaction. 
Lipton group reported the first catalytic asymmetric Strecker reaction using the 
cyclic dipeptide 11 as the catalyst in 1996 (Scheme 1.2).8a The guanidine group of 11 
was crucial for enantioselectivity as replacing it with an imidazole failed to achieve 
any enantioselectivity. Good to excellent enantioselectivities (80->99% ee) were 
usually obtained with aromatic N-benzhydryl imines using only 2 mol% catalyst 11. 
Low enantioselectivities were obtained with heteroaromatic or aliphatic imines. 
However, the results were not reproducible by Kunz et al., casting doubts over the 
original paper.8b 
 Chiral guanidine 8b was found to be the best catalysts for the Michael reaction of 
glycinate 15 to ethyl acrylate 16 giving conjugated addition products 17 with 30% ee 
by Ma and co-workers (Scheme 1.3, eq 1).9 The same group also showed that 
guanidine 8a could effectively catalyze the reaction between anthrone and 
N-methylmaleimide (Scheme 1.3, eq 2).10 The Michael adduct 21 was preferentially 
formed in 70% ee over the cycloadduct.  
                                                        
8 (a) Iyer, M. S.; Gigstad, K. M.; Namdev, N. D.; Lipton, M. J. Am. Chem. Soc. 1996, 118, 4910–4911; (b) Becker, 
C.; Hoben, C.; Schollmeyer, D.; Scherr, G.; Kunz, H. Eur. J. Org. Chem. 2005, 1497–1499. 
9 Ma, D.; Cheng, K. Tetrahedron: Asymmetry 1999, 10, 713–719. 
10 Peng, B.; Cheng, K.-J.; Ma, D. Chin. J. Chem. 2000, 18, 411–413. 
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8a (10 mol %)
21







17 99% yeild, 30% ee
(1)
(2)
 Scheme 1.3 Ma’s chiral guanidine catalyzed Michael reaction. 
1.2 Mono-to-polycyclic guanidines  
1.2.1 Monocyclic guanidines 
In 2001, Ishikawa used the monocyclic guanidine 22a to catalyze the Michael 
reaction of glycinate 14 under solvent free condition (Scheme 1.4, eq 1).11a High 
yields (85%) and excellent ees (97%) were obtained with the reaction of ethyl acrylate 
16. However, the reaction of acrylonitrile 23 only gave the product 25 in 79% yield 
and 55% ee. In addition, it required a reaction time of 3-5 days. Furthermore, the 
hydroxyl group in the catalyst 22a was vital for the reaction. Thus, Ishikawa and 
co-workers tried to optimize this reaction further with monocyclic guanidine 22d and 
22e but with no improvement.11b Ishikawa et al. also attempted the Michael reaction 
between 2-cyclopenten-1-one 25 and dibenzyl malonates 26 by using monocyclic 
guanidine 22a as catalyst which gave 43% ee with an acceptable yield of 65% 
                                                        
11 (a) Ishikawa, T.; Araki, Y.; Kumamoto, T.; Seki, H.; Fukuda, K.; Isobe, T. Chem. Commun. 2001, 245–246. (b) 
Ryoda, A.; Yajima, N.; Haga, T.; Kumamoto, T.; Nakanishi, W.; Kawahata, M.; Yamaguchi, K.; Ishikawa, T. J. Org. 
Chem. 2008, 73, 133–141. 
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(Scheme 1.4, eq 2).12  









17 R = CO2Et (85% yield, 97% ee)
24 R = CN (79% yield, 55% ee)
15 16 R = CO2Et
23 R = CN
BnO2C CO2Bn
R
22a (10 mol %)
27a 65% yield, 43% ee
27b 82% yield, 40% ee
a: CHCl3, reflux, 12 d;





26a R = H





22a: R1 = (R)-Bn, R2 = Ph, R3 = Me;
22b: R1 = (S)-Bn, R2 = Ph, R3 = Me;
22c: R1 = (R)-Ph, R2 = Ph, R3 = Me;
22d: R1 = (R)-Bn, R2 = 2-MeC6H4, R3 = Me;






Scheme 1.4 Ishikawa’s chiral guanidine catalyzed Michael reaction of glycinate. 
 
Scheme 1.5 Enantioselective Mannich reactions of various N-Boc protected imines 
catalyzed by guanidine ent-22a. 
By using monocyclic guanidine ent-22a as a catalyst, Kobayashi et al. reported 
the Mannich reactions to give α,β-diamino esters 30 from N-Boc protected imines 28 
with high syn selectivities and enantioselectivities (Scheme 1.5). 13 Utilizing 
monocyclic guanidine ent-22d as a catalyst, Ishikawa et al. investigated the 6-exo-trig 
                                                        
12 Kumamoto, T.; Ebine, K.; Endo, M.; Araki, Y.; Fushimi, Y.; Miyamoto, I.; Ishikawa, T.; Isobe, T.; Fukuda, K. 
Heterocycles 2005, 66, 347–359. 
13 Kobayashi, S.; Yazaki, R.; Seki, K.; Yamashita, Y. Angew. Chem. Int. Ed. 2008, 47, 5613–5615. 
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intramolecular oxa-Michael cyclization reaction of phenol 31 as an entry to chiral 
chromane 32 (Scheme 1.6).14 The E/Z geometry of the α,β-unsaturated ester played a 
crucial role in determining the enantioselectivity. The Z isomer only gave moderate ee 
values. 
 































33 (20 mol %)
XOOH/Tol. (10 equiv.), rt, 1d
X = tBu, 34% yield, 49% ee
X = PhC(Me)2, 52% yield, 64% ee 33
(1)
(2)
Scheme 1.7 Monocyclic Guanidine promoted epoxidation. 
 Ishikawa developed a similar monocyclic guanidine 33 as catalyst on 
enantioselective epoxidation of chalcone 34a (Scheme 1.7, eq 1).15 With 20 mol% of 
the monocyclic guanidine 33, epoxide 35a was obtained in 49% and 64% ees 
respectively when two different hydroperoxides were used. The enantioselective 
epoxidation of enone 37 was promoted by a stoichiometric amount of another 
                                                        
14 Saito, N.; Ryoda, A.; Nakanishi, W.; Kumamoto, T.; Ishikawa, T. Eur. J. Org. Chem. 2008, 2759–2766. 
15 Ishikawa, T.; Isobe, T. Chem. Eur. J. 2002, 8, 552–557. 
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monocyclic guanidine 36, and this gave a moderate yield of 38 (Scheme 1.7, eq 2).16  
 
Scheme 1.8 Chiral guanidine 38 catalyzed borane reduction of phenacyl bromide. 
 Basavaiah and co-workers reported that guanidine 38 catalyzed borane-mediated 
reduction of phenacyl bromide (Scheme 1.8).17 Higher ee values were achieved when 
the reaction was conducted in reflux condition compared to room temperature. 
However, further research showed that guanidine 38 was not the active catalytic 
species involved at high temperature.  
1.2.2 Bicyclic guanidines 
In 1999, Corey and Grogan initially designed the C2-symmetric bicyclic guanidine 
1c and applied it to catalytic asymmetric Strecker reaction (Scheme 1.9).18a Moderate 
to good ee values were achieved. Subsequently, Berg et al. reported that the bicyclic 
guanidine 1c was able to catalyze the transamination reaction involved in 1,3-proton 
shift of imines with modest ees.18b  
Recently, Tan’s group applied bicyclic guanidine 1b on enantioselective Michael 
reactions between different donors and acceptors (Scheme 1.9).19 They reported that 
                                                        
16 (a) McManus, J. C.; Carey, J. S.; Taylor, R. J. K.; Synlett 2003, 365–368; (b) McManus, J. C.; Genski, T.; Carey, 
J. S.; Taylor, R. J. K. Synlett 2003, 369–371. 
17 Basavaiah, D.; Rao, K. V.; Reddy, B. S. Tetrahedron: Asymmetry 2006, 17, 1036–1040. 
18 (a) Corey, E. J.; Grogan, M. J. Org. Lett. 1999, 1, 157–160. (b) Hjelmencrantz, A.; Berg, U. J. Org. Chem. 2002, 
67, 3585–3594. 
19 (a) Ye, W.; Xu, J.; Tan, C.-T.; Tan, C.-H. Tetrahedron Lett. 2005, 46, 6875–6878. (b) Jiang, Z.; Ye, W.; Yang, Y.; 
Tan, C.-H. Adv. Synth. Catal. 2008, 350, 2345–2351. (c) Ye, W.; Jiang, Z.; Zhao, Y.; Goh, S. L. M.; Leow, D.; Soh, 
Y.-T.; Tan, C.-H. Adv. Synth. Catal. 2007, 349, 2454–2458. (d) Jiang, Z.; Yang, Y.; Pan, Y.; Zhao, Y.; Liu, H.; Tan, 
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bicyclic guanidine 1b could catalyze the conjugate addition of α-fluoro-β-ketoesters 
providing products with chiral quaternary fluorinated carbon in high 
enantioselectivities and diastereoselectivities. This method allows the convenient 
preparation of chiral fluorinated compounds. The products obtained were not only in 







1a R = Bn
1b R = tBu












































































































Scheme 1.9 The application of bicyclic guanidine 1 for different reactions.   
Tan and co-workers reported the addition of dialkyl phosphites and diphenyl 
                                                                                                                                                               
C.-H. Chem. Eur. J. 2009, 15, 4925–4930. (e) Jiang, Z.; Pan, Y.; Zhao, Y.; Ma, T.; Lee, R.; Yang, Y.; Huang, K.-W.; 
Wong, M. W.; Tan, C.-H. Angew. Chem. Int. Ed. 2009, 48, 3627–3631. 
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phosphonite to various activated alkenes.20a Subsequently, it was discovered that 
chiral bicyclic guanidine 1b was effective in catalyzing phospha-Michael reactions of 
nitroalkenes. Excellent enantioselectivities were generally obtained for various 
nitroalkenes with di-(1-naphthyl) phosphine oxide at –40 °C.20b  
Tan’s group reported that bicyclic guanidine 1b was also efficient in catalyzing the 
tandem conjugate addition – enantioselective protonation reaction.21 Optically pure 
analogues of cysteine and cystine could be obtained using this methodology. Highly 
enantioselective deuteration reaction could also be achieved. A small but significant 
level of kinetic isotope effect was also observed. 
By using bicyclic guanidine 1a, Tan and co-workers reported the first case of 
highly enantioselective base-catalyzed Diels-Alder reaction between anthrones and 
various dienophiles. 22  Both Diels-Alder and Michael adducts were obtained in 
excellent yields, high regioselectivities and high enantioselectivities.  
Moreover, bicyclic guanidine 1b was found to catalyze enantioselective Mannich 
reaction between α-fluoro compounds and imines for the synthesis of α-fluorinated 
β-amino acid derivatives with high regioselectivities and high enantioselectivities.23 
A transient enolate was obtained via retro-Claisen or decarboxylation followed by 
protonation to give enantiopure fluorinated compounds. Similarly, chiral bicyclic 
guanidine 1b catalyzed enantioselective Electrophilic Amination reaction to give 
                                                        
20 (a) Jiang, Z.; Zhang, Y.; Ye, W.; Tan, C.-H. Tetrahedron Lett. 2007, 48, 51–54. (b) Fu, X.; Jiang, Z.; Tan, C.-H. 
Chem. Commun. 2007, 5058–5060. 
21 Leow, D.; Lin, S.; Chittimalla, S. K.; Fu, X.; Tan, C.-H. Angew. Chem. Int. Ed. 2008, 47, 5641–5645. 
22 Shen, J.; Nguyen, T. T.; Goh, Y.-P.; Ye, W.; Fu, X.; Xu, J.; Tan, C.-H. J. Am. Chem. Soc. 2006, 128, 
13692–13693. 
23 Pan, Y.; Zhao, Y.; Ma, T.; Yang, Y.; Liu, H.; Jiang, Z.; Tan, C.-H. Chem. Eur. J. 2010, 16, 779–782. 
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chiral α-fluoro-α-amino compounds with high enantioselectivities.24  
 
Scheme 1.10 The application of bicyclic guanidine 50 for different reactions. 
 
Scheme 1.11 Chiral guanidine 57 catalyzed nitro Michael reaction. 
Ishikawa applied another C2-symmetrical bicyclic guanidine 50a in the TMS 
cyanation of aliphatic aldehydes and ketones, affording the products 52 in moderate 
ees (Scheme 1.10, eq 1).25 Ishikawa’s modified bicyclic guanidine 50b was used as 
the asymmetric reagent for the kinetic silylation of secondary alcohols (Scheme 1.10, 
eq 2).26 The reactions required six days for completion. The yield was improved by 
conducting the reaction under reflux condition without compromising the 
enantioselectivity. Bicyclic guanidine 50a (1 equiv.) was also found to mediate the 
kinetic azidation of racemic 1-indanol 53 (Scheme 1.10, eq 3). The product was 
                                                        
24 Zhao, Y.; Pan, Y.; Liu, H.; Ma, T.; Yang, Y.; Jiang, Z.; Tan, C.-H. Manscript in preparation. 
25 Kitani, Y.; Kumamoto, T.; Isobe, T.; Fukuda, K.; Ishikawa, T. Adv. Synth. Catal. 2005, 347, 1653–1658. 
26 Isobe, T., Fukuda, K.; Araki, Y.; Ishikawa, T. Chem. Commun. 2001, 243–244. 
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obtained in 30% ee.4 Davis also developed another bicyclic guanidine 39 to catalyze 
the nitro Michael reaction between 58 and 59, giving products 60 in 9-12% ee 
(Scheme 1.11).27  
1.3 Axial chiral guanidines  
 
Scheme 1.12 Terada’s axially chiral guanidine catalyzed enantioselective reactions. 
The chiral guanidine catalysts discussed above are either acyclic guanidine with 
chiral side chains or mono-to-polycyclic systems with central chiralities. Recently, 
Terada and co-workers were able to incorporate axially chiral binaphthyl backbone 
with the guanidine functional group (Scheme 1.12).28 This axially chiral guanidine 
61a was found to be a highly efficient catalyst for the Michael reaction between a 
variety of conjugated nitroalkenes 63 and several 1,3-dicarbonyl compounds 64, 
featuring both high yields and excellent enantioselectivities (up to 98% ee), with 
catalyst loading as low as 0.4-2 mol% (Scheme 1.12, eq 1).28a 
                                                        
27 Davis, A. P.; Dempsey, K. J. Tetrahedron: Asymmetry 1995, 6, 2829–2840. 
28 (a) Terada, M.; Ube, H.; Yaguchi, Y. J. Am. Chem. Soc. 2006, 128, 1454–1455. (b) Terada, M.; Ikehara, T.; Ube, 




Terada et al. also demonstrated that the same type of axially chiral guanidine 
could catalyze the addition of diphenyl phosphite 66 to nitroalkenes 63 with high 
enantioselectivities (Scheme 1.12, eq 2). Guanidine 61b was selected as the optimum 
catalyst and only a low catalyst loading of 1 mol% was required. Molecular sieves 
were required as acid scavengers to remove acid impurities from the diphenyl 
phosphate. The reactions achieved high yields and enantioselectivities with aromatic 
nitroalkenes. For the aliphatic ones, 5 mol% of catalyst was required and the reactions 
were conducted at a lower temperature of −60 °C (Scheme 1.12, eq 1).28b 
Subsequently, Terada designed another new type of chiral guanidine catalysts like 
62, which introduced an axially chiral binaphthyl backbone with a 
seven-membered-ring structure.28c This axially chiral guanidine was found to be a 
highly efficient catalyst for the electrophilic amination reactions between 
α-monosubstituted 1, 3-dicarbonyl compounds 64 and azodicarboxylate 68 with 
catalyst loading as low as 0.05 mol% (Scheme 1.12, eq 3). The bulkiness of the 
azodicarboxylate was also found to be crucial for the enantioselectivities. The scope 
of the reaction was examined with the optimized conditions, yielding products with 
good to excellent ee values. However, β-keto lactone did not work well with the 
catalyst. 
1.4 Chiral Guanidine Salts 




Scheme 1.13 Guanidine salt catalyzed phase transfer asymmetric epoxidation of 
chalcones. 
In 2003, Murphy reported the epoxidation of chalcones 34 using tetracyclic 
guanidinium salt 70a as the phase transfer catalyst.29a High enantioselectivities were 
obtained for two examples (Scheme 1.13, eq1). These results are comparable with the 
existing phase transfer catalysts for the epoxidation reaction. Nagasawa and 
co-workers also attempted the phase-transfer catalytic epoxidation of chalcones with 
his pentacyclic guanidinium salt 71 (Scheme 1.13, eq2).29c The reaction took about 5 
days to complete with moderate ees. A new pentacyclic guanidinium salt 72 was 
applied to improve the reaction time and yields. A follow-up investigation led to a 
newly designed acyclic hydroxyl-guanidinium salt 73, which slightly improved the 
enantioselectivities (Scheme 1.13, eq3). 29d 
                                                        
29 (a) Allingham, M. T.; Howard-Jones, A.; Murphy, P. J.; Thomas, D. A.; Caulkett, P. W. R.; Tetrahedron Lett. 
2003, 44, 8677–8680. (b) Howard-Jones, A.; Murphy, P. J.; Thomas, D. A. J. Org. Chem. 1999, 64, 1039–1041. (c) 
Kita, T.; Shin, B.; Hashimoto, Y.; Nagasawa, K. Heterocycles 2007, 73, 241–247. (d) Shin, B.; Tanaka, S.; Kita, T.; 




Scheme 1.14 Guanidine salt catalyzed phase transfer asymmetric alkylation. 
 In the presence of 30 mol% of pentacyclic guanidinium salt 71 and under phase 
transfer conditions, glycinate 15 underwent alkylation reaction with various alkyl 
halides (Scheme 1.14, eq 1).30 The alkylated products were generated with good ee 
values in the range of 76-90%. However, long reaction time was required for 
achieving moderate to good yields. It was also observed that the stereochemical 
outcome was controlled by the configuration of the spiro-ether rings of the 
guanidinium catalyst. The substituent (methyl group) on the spiro ether rings of 79 
was found to play a key role in effective asymmetric induction. Murphy’s tetracyclic 
guanidinium 70a also catalyzed the phase transfer alkylation of glycinate with benzyl 
bromide in 86% ee (Scheme 1.14, eq 2).29a  
 
Scheme 1.15 Guanidine salt catalyzed enantioselective Phospha-Mannich reactions. 
                                                        
30 Kita, T.; Georgieva, A.; Hashimoto, Y.; Nakata, T.; Nagasawa, K. Angew. Chem. Int. Ed. 2002, 41, 2832–2834.  
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Very recently, Tan’s group developed a novel guanidinium catalyst 77•HBArF, 
which was obtained in a single step from commercially available diamine. Using this 
catalyst, asymmetric Phospha-Mannich reaction has been developed using secondary 
phosphine oxides and H-phosphinates as the P-nucleophile. K2CO3 needed to be 
added as an additive. A series of α-amino phosphine oxides and α-amino phosphinate 
were prepared with high ees (Scheme 1.15).31  
1.4.2 Guanidine salts as hydrogen-donor catalysts 
 
Scheme 1.16 Conjugate additions of pyrrolidine to lactones 79 catalyzed by various 
guanidine salts (relative rate increases are indicated). 
Since guanidinium 81b was firstly reported to catalyze the Michael reaction of 
pyrrolidine to α,β-unsaturated lactones (Scheme 1.16),32 several guanidine salts were 
found to catalyze this reaction without any asymmetric induction.32, 29a-b It has been 
proven that guanidine as hydrogen-donor catalyst can activate lactones and increase 
their reactivities. 
Recently, Jacobsen and co-workers made a breakthrough on hydrogen-donor 
                                                        
31 Fu, X.; Loh, W.-T.; Zhan, Y.; Chen, T.; Liu, H.; Wang, J.; Tan, C.-H. Angew. Chem. Int. Ed. 2009, 48, 
7387–7390. 
32 (a) Alcázar, V.; Morán, J. R.; de Mendoza, J. Tetrahedron Lett. 1995, 36, 3941–3944. (b) Nagasawa, K.; 
Georgieva, A.; Takahashi, H.; Nakata, T. Tetrahedron 2001, 57, 8959–8964. (c) Martín-Portugués, M.; Alcázar, V.; 
Prados, P.; de Mendoza, J. Tetrahedron 2002, 58, 2951–2955. 
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guanidine catalyst by developing a C2-symmetric guanidinium salt 82 to catalyze the 
enantioselective Claisen rearrangement reactions with good to high enantioslectivities 
(Scheme 1.17).33 High anti diastereoselectivities were obtained as predicted by a 
six-membered chair-like transition state. However, the reactions were generally slow. 
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Scheme 1.17 Enantioselective Claisen rearrangement reactions catalyzed by 
guanidinium salt 82. 
1.5 Bifunctional guanidine catalysts 
 Nagasawa and co-workers designed a bifunctional C2-symmetric 
guanidine–thiourea catalyst 85 and applied to Henry reactions (Scheme 1.17).34 The 
bifunctional catalyst 85 effectively activated both the nucleophile and electrophile, 
separated by a chiral spacer. The long alkyl chain group promoted hydrophobic 
self-aggregation, increasing the reactivity and selectivity of this phase transfer 
                                                        
33 Uyeda, C.; Jacobsen, E. N. J. Am. Chem. Soc. 2008, 130, 9228–9229. 
34 (a) Sohtome, Y.; Hashimoto, Y.; Nagasawa, K. Adv. Synth. Catal. 2005, 347, 1643–1648. (b) Sohtome, Y.; 
Takemura, N.; Iguchi, T.; Hashimoto, Y.; Nagasawa, K. Synlett 2006, 144–146. (c) Sohtome, Y.; Hashimoto, Y.; 
Nagasawa, K. Eur. J. Org. Chem. 2006, 2894–2897. (d) Sohtome, Y.; Takemura, N.; Takada, K.; Takagi, R.; Iguchi, 
T.; Nagasawa, K. Chem. Asian. J. 2007, 2, 1150–1160. (e) Takada, K.; Takemura, N.; Cho, K.; Sohtome, Y.; 
Nagasawa, K. Tetrahedron Lett. 2008, 49, 1623–1626. 
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reaction. The optimized conditions were applied to various aldehydes 5 and 
nitroalkanes 89. Generally, good ee values were obtained. In all the examples, 
syn-nitroaldol products were obtained in excellent diastereoselectivities (Scheme 1.18, 
eq 1). A study on the diastereoselective Henry reactions of N,N-dibenzyl α-amino 
aldehydes 87 with nitromethane 6 was also conducted (Scheme 1.18, eq 2), 
Guanidine-thiourea (R,R)-85 catalyst turned out to be the best matched catalyst. The 
anti diastereomer was produced in excellent ee values of >95% in all examples. The 
asymmetric Henry reactions of α-ketoesters catalyzed by the guanidine (R,R)-85 have 
also been explored (Scheme 1.18, eq 3).34e Good to excellent enantioselectivities were 
obtained with various α-ketoesters 90 and nitroalkanes 89 at temperatures between 
−35 to −20 °C. However, poor ee values were obtained with aromatic α-ketoesters. 
 
Scheme 1.18 Guanidine–thiourea 85 catalyzed Henry reaction. 
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 Recently, Feng and co-workers designed and synthesized a bifunctional guanidine 
92 featuring a chiral amino amide backbone (Scheme 1.19).35 It was applied to the 
asymmetric 1,4-addition of β-ketoesters 93 to nitroolefins 63 with dual activation in 
one molecule, which afforded a wide range of products 94 containing quaternary 
chiral centers with high ee values and excellent diastereomeric ratios. They have also 
shown that the amide subunit in the guanidine had a significant impact on the 
enantioselectivity of the reaction.  
 
Scheme 1.19 Bifunctional guanidine 92 catalyzed 1,4-addition reaction. 
1.7 Summary 
 Chiral guanidines function as effective Brønsted base catalyst for a variety of 
reactions. They have also shown to be effective Hydrogen-donor catalysts as well as 
phase transfer catalysts. Unfortunately, those chiral guanidines can only apply in a 
specific types of reaction. Novel types of chiral guanidines need to be further explored. 
Among the existing chiral guanidines, only bicyclic guanidines 1 were shown as a 
general type of enantioselective catalysts. However, the reaction varieties were still 
limited. We are interested in discovering novel enantioselective reactions by applying 
bicyclic guaidines 1. 
                                                        














 Enantioselective Synthesis of Chiral Allenoates  





2.1 Introduction to Enantioselective Synthesis of Axial Chiral Allenes 
2.1.1 Allenes in nature and synthesis 
 Allenes are a class of unique compounds with two π- orbitals perpendicular to 
each other. Nowadays, about 150 natural products with allenic or cumulenic structure 
are known. The majority of these natural allenes can be divided into three classes, as 
linear allenes, allenic carotinoids and terpenoids, and bromoallenes (Figure 2.1). 
Inspired by the intriguing biological activities of many allenic natural poducts, lots of 
functionalized allenes obtained exhibit impressive activities as mechanism-based 
enzyme inhibitors, cytotoxic, or antiviral agents.1 Moreover, almost all of the allenic 















Figure 2.1 Structures of natural allenes: linear allene (marasin), allenic carotinoid 
(grasshopper ketone) and bromoallene (panacene).  
The first reported synthetic allene could be dated back to 1887,2 and its structure 
was confirmed in 1954.3 For a long period of time, allenes were considered as highly 
unstable, which retarded the development of the chemistry of allenes. Recently, 
chemists have paid a great attention to allenes4 due to their interesting properties as 
follows: (1) with up to four substituents, allenes provide synthetic diversity; (2) the 
                                                        
1 For a review on allenic natural products, see: Hoffmann-Röder, A.; Krause, N. Angew. Chem. Int. Ed. 2004, 43, 
1196–1216. 
2 Burton, B. S.; Pechman, H. V. Chem. Ber. 1887, 20, 145–149. 
3 Jones, E. R. H.; Mansfield, G. H.; Whiting, M. C. J. Chem. Soc. 1954, 3208–3212. 
4 (a) Modern Allene Chemistry; Krause, N., Hashmi, A. S. K., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: 
Weinheim, Germany 2004. For recent reviews, see: (b) Ma, S. Acc. Chem. Res. 2003, 36, 701–712. (c) Wei, L.-L.; 




reactivity and electron density of each carbon atom in each allene unit can be tuned by 
the substituent effect; (3) the inherent axial chirality provides a challenge for the 
highly stereoselective synthesis of optically active allenes and the transfer of the 
allenes into final products. 
2.1.2 Enantioselective synthesis of chiral allenes 
Due to the ease of availability of chiral propargylic alcohols, many chiral allenes 
are prepared through chirality transfer.4a, 5a Relatively less examples are developed 
using enantioselective catalysts with pro-chiral substrates.4a, 5a Some of the earlier 
examples include various palladium catalyzed reactions such as cross-coupling with 
allenyl-metal reagents,5b hydroboration5c and hydrosilylation of butadiynes.5d, 5e 
However, non of them achieved satisfactory enantioselectivity. Hayashi and 
co-workers originally reported a substitution reaction which was catalyzed by a 
palladium-bisphosphine complex and the substrates were achiral conjugate dienes. 6a 
An asymmetric version for synthesis of chiral allenes can be easily achieved by 
modification of the catalyst using an appropriate chiral phosphine ligand 97 (scheme 
2.1). The enantioselectivity of the system was sufficiently high, up to 89% ee.6b   
 
Scheme 2.1 Palladium-catalyzed asymmetric synthesis of allene 98 from bromodiene 
95 and nucleophile 96.  
                                                        
5 (a) Hoffmann-Röder, A.; Krause, N. Angew. Chem. Int. Ed. 2002, 41, 2933–2935. (b) de Graaf, W.; Boersma, J.; 
van Koten, G.; Elsevier, C. J. J. Organomet. Chem. 1989, 378, 115–124. (c) Matsumoto, Y.; Naito, M.; Uozumi, Y.; 
Hayashi, T. J. Chem. Soc., Chem. Commun. I993, 1468–1469. (d) Tillack, A.; Michalik, D.; Koy, C.; Michalik, M. 
Tetrahedron Lett. 1999, 40, 6567–6568. (e) Tillack, A.; Koy, C.; Michalik, D.; Fisher, C. J. Organomet. Chem. 
2000, 603, 116–121. 
6 (a) Ogasawara, M.; Ikeda, H.; Hayashi, T. Angew. Chem. Int. Ed. 2000, 39, 1042–1044. (b) Ogasawara, M.; 
Ikeda, H.; Nagano, T.; Hayashi, T. J. Am. Chem. Soc. 2001, 123, 2089–2090. 
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Hayashi group reported another successful example, which was 
palladium-catalyzed asymmetric hydrosilylation of 4-substituted 1-buten-3-ynes.7a 
The synthetic important axial chiral allenylsilanes of up to 90% ee were obtained by 
their catalytic conditions. The same group found that a new reaction system consisting 
of an enynone 99, an aryltitanate reagent 100, chlorotrimethylsilane 101 and a chiral 
phosphine−rhodium catalyst 102 gave a high yield of allenylalkenyl silyl ether 104 as 
a 1,6-addition product (Scheme 2.2). When a special chiral bisphosphine ligand, 
(R)-segphos 103, was applied in the system, high ees (up to 93%) were achieved.    
 
Scheme 2.2 Rhodium-catalyzed asymmetric 1,6-addition of aryltitanates to enynones 
giving chiral allenylalkenyl silyl ethers.  
 
Scheme 2.3 Dynamic kinetic asymmetric allylic alkylations of allenes. 
Trost and co-workers have developed highly enantioselective conditions for the 
                                                        
7 (a) Han, J. W.; Tokunaga, N.; Hayashi, T. J. Am. Chem. Soc. 2001, 123, 12915–12916. (b) Hayashi, T.; Tokunaga, 
N.; Inoue, K. Org. Lett. 2004, 6, 305–307. 
Chapter 2 
 37
asymmetric allylic alkylation (AAA) of racemic allenes 105 with nucleophiles 106 
like malonates and amines through dynamic kinetic asymmetric transformations 
(DYKAT) (Scheme 2.3, eq 1).8a These DYKAT products can be easily transferred into 
useful products with multiple stereogenic centers as well as olefin geometry, and the 
chirality is completed transferred. At the same time, other groups reported similar 
dynamic kinetic asymmetric transformations of 2,3-allenyl phosphates 109 using a 
combination of zerovalent palladium complexes and (R)-segphos ligand, affording the 
corresponding optically active 1-aminated allenes 111 with good yields and 
enantiometric excess of up to 97% ee (Scheme 2.3, eq 2).8b  


















P(m-MeOC6H4)2 72-90% yield93-98% ee
114
 
Scheme 2.4 Olefination of ketenes with diazoacetate catalyzed by Fe(TCP)Cl. 
Recently, Tang et al. developed an efficient method for the synthesis of allenes by 
olefination of ketenes. Chiral allenic esters 115 were prepared with high 
enantioselectivities (93−98% ee) in good yields (72−90 %), using an iron 
porphyrin-catalyzed olefination of ketenes 112 with ethyl diazoacetate 113 in the 
presence of a chiral phosphine 114 (Scheme 2.4). 9  The chiral phosphine was 
                                                        
8 (a) Trost, B. M.; Fandrick, D. R.; Dinh, D. C. J. Am. Chem. Soc. 2005, 127, 14186–14187. (b) Imada, Y.; Nishida, 
M.; Kutsuwa, K.; Murahashi, S.-I.; Naota, T. Org. Lett. 2005, 7, 5837–5839. 
9 Li, C.-Y.; Wang, X.-B.; Sun, X.-L.; Tang, Y.; Zheng, J.-C.; Xu, Z.-H.; Zhou, Y.-G.; Dai, L.-X. J. Am. Chem. Soc. 
2007, 129, 1494–1495. 
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recovered and reused without losing ees. The ylide olefination mechanism was 
experimentally confirmed.  
2.1.3 Synthesis of allenes by isomerization of alkynes 
Isomerization is a chemical structural re-organization process in which an atom or 
group rearranges within a molecule without a change in the molecular formula. The 
Brønsted base catalyzed 1,3-prototropic shift reaction, proceeding through 
de-protonation and protonation sequences, allows allenes to be prepared directly from 
alkynes.10 To date only a Cinchona alkaloid phase transfer catalyst (PTC) 117 has 
afforded modest enantioselectivity (35% ee) of allene 76 for catalytic asymmetric 
isomerization of alkyne 116 (Scheme 2.5).11 Alkynes are about two kcal mol-1 more 
stable than their corresponding allenes.12 Therefore kinetic control is necessary for 
obtaining good yields of allenes. 
 
Scheme 2.5 Catalytic synthesis of allenes via isomerization of alkynes under phase 
transfer catalyzed conditions. 
2.1.4 Summary 
 Recent developments in the area of catalytic enantioselective synthesis of axial 
chiral allenes have been summarized. Only a few established enantioslective catalytic 
                                                        
10 (a) Jung, M. E.; Node, M.; Pfluger, R. W.; Lyster, M. A.; Lowe, J. A., III J. Org. Chem. 1982, 47, 1150–1152. (b) 
Yasukouchi, T.; Kanematsu, K. Tetrahedron Lett. 1989, 30, 6559–6562. (c) Ma, D.; Yu, Y.; Lu, X. J. Org. Chem. 
1989, 54, 1105–1109. 
11 Oku, M.; Arai, S.; Katayama, K.; Shioiri, T. Synlett. 2000, 493–494. 
12 (a) Radom, L.; Lathan, W. A.; Hehre, W. J.; Pople, J. A. J. Am. Chem. Soc. 1971, 93, 5339–5342. (b) Kakkar, R. 
Int. J. Quantum Chem. 2003, 94, 93–104. (c) Xu, B.; Hammond, G. B. Angew. Chem. Int. Ed. 2008, 47, 689–692. 
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systems were reported using metal complexes. Relatively no successful example was 
presented by using organocatalysts. Therefore, we are keen to utilize organocatalyst 
for synthesis of allenes with high enantioselectivities by isomerization of alkynes, 
which can be one of the most practical methods for synthesis of allenes.  
2.2 Enantioselective Synthesis of Chiral Allenoates by 
Guanidine-Catalyzed Isomerization of 3-Alkynoates 
2.2.1 Synthesis of 3-alkynoates 
 We took advantages of a convenient preparation of functionalized 3-alkynoates 
121 starting form commercial available terminal alkynes 119 and tert-butyl 
2-diazoacetate 120, which was reported by Fu’s group (Scheme 2.7).13 However, we 
can always obtained the desired products 121 along with a small amount of their 
corresponding allenes 122 (5−10%) as a racemic form. It was troublesome to purify 
the 3-alkynoates 121 by flash chromatography since the allene isomers 122 could not 
be removed. Thus pyridinium tribromide (PyHBr3) was developed as a scavenger 
reagent to remove the allenoates 80 without destroying the 3-alkynoates 121 (method 
A, Scheme 2.6). In certain instances, when hydroxyl groups were presented in the 
3-alkynoates 121, an alternative method was employed for purification since the 
former method was not efficient (method B, Scheme 2.6). 
 
Scheme 2.6 Standard synthesis of 3-alkynoates.  
                                                        
13 Suárez, A.; Fu, G. C. Angew. Chem. Int. Ed. 2004, 43, 3580–3582. 
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Due to the high price of commercially available tert-butyl 2-diazoacetate 120 and 
large quantity needed, we prepared tert-butyl 2-diazoacetate 120 from tert-butyl 
acetoacetate in a two-step protocol (Scheme 2.7).14 Reactions were conducted 10 
gram scale without any incident.  
 
Scheme 2.7 Preparation of tert-butyl 2-diazoacetate 120.  
2.2.2 An Aziridine-Based Synthesis of Chiral Bicyclic Guanidines 
 
Scheme 2.8 Synthesis of C2-symmetrical chiral bicyclic guanidines. 
Bicyclic chiral guanidine catalyst 1b was prepared according to the reported 
procedure as shown above (Scheme 2.8).15 N-Tosyl aziridine 126 was readily prepared 
from its corresponding commercially available α-amino alcohols 125 with a two step 
protocol. Triamine unit 127 was easily obtained by treating N-tosyl aziridine 126 in 
MeOH saturated with NH3 gas in a sealed vessel followed by refluxing in MeCN for 3 
days. The nucleophilic attack occurs preferentially at the sterically least hindered 
carbon atom. The subsequent removal of tosyl groups was achieved by using sodium 
                                                        
14 Johnson, J.; Nicewicz, D.; Brétéché, G.; Bryan, C. Org. Synth. 2008, 85, 278–286. 
15 Ye, W.; Leow, D.; Goh, S. L. M.; Tan, C.-T.; Chian, C.-H.; Tan, C.-H. Tetrahedron Lett. 2006, 47, 1007–1010. 
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in liquid ammonia. The crude triamine 128 was then subjected to the final cyclization 
step, leading to the guanidine 1b. It was basified with 5M KOH aqueous solution 
instead of solid K2CO3 and subsequent re-crystallized from hexane.  
 
2.2.3 Optimization studies on isomerization of 3-alkynoates 
 
Scheme 2.9 Chiral bicyclic guanidine 1b catalyzed isomerization of 3-alkynoate 121a 
in different conditions. 
 3-Alkynoate 121a was selected for the model reaction. Triethylamine (Et3N) or 
1,5,7-triazabicyclo[4.4.0]dec-1-ene (TBD) was used as catalyst for the achiral version 
isomerization, and we were keen to develop bicyclic guanidine 1b as enantioselective 
catalyst for the asymmetric version (Scheme 2.9). In our optimization studies with 
allenoate 121a, we screened different solvent for this proton transfer reaction at room 
temperature. The common solvents gave low enationselectivities (Table 2.1, entries 
1-3). Hexane was found to be the best solvent but only moderate ee value was 
obtained (Table 2.1, entry 4). Both conversion and ee values increased dramatically 
when the reaction temperature and concentration were lowered (entries 5–6). 
Interestingly, decreasing the catalyst loading led to even higher enantioselectivities 
(entries 4–5). However, the reaction conversion could not be raised further with 
longer reaction time. The ee values were monitored over a time course. At the start of 
the reaction, the ee value was 92% and it rose briefly to 94% after 4 h. As reaction 
progressed, it dropped and maintained at 91%. 
Chapter 2 
 42
Table 2.1 Optimization on the isomerization of 3-alkynoate 121a in different 
conditions (Scheme 2.9). 
 
entry solvent 1b/mol % conc./M temp/oC yield/%a ee/%b
1 CH2Cl2 10 0.2 rt ND 0 
2 THF 10 0.2 rt ND 35 
3 Toluene 10 0.2 rt ND 37 
4 hexane 10 0.2 rt >99 (65) 68 
5 hexane 10 3.0×10-3 rt >99 (56) 82 
6 hexane 10 3.0×10-3 −20 >99 (75) 89 
7 hexane 5 3.0×10-3 −20 >99 (75) 91 
8 hexane 1 3.0×10-3 −20 >99 (59) 94 
a Isolated combined yield of 121a and 122a; % of 122a is in parentheses and was 
determined by 1H NMR. b Chiral HPLC analysis. 




Scheme 2.10 Enantioselective isomerization of 4-aryl 3-alkynoates 121a-h. a 
Conversion of 122 was determined by 1H NMR. b Chiral HPLC analysis. c 4 mol% of 
1b used. d THF was used as solvent. e Isolated yield of allenoate 122. 
With the optimized condition on hand, we examined the scope with different 
4-aryl 3-alkynoates 121a-h (Scheme 2.10). Both electron-withdrawing and 
electron-donating substituents did not affect the reactivity and enantioselectivity 
(Scheme 2.10, 122a–d). Naphthyl and heteroaromatic groups also gave excellent ees 
(Scheme 2.10, 122e–f). With the exceptions of allenoates 122g and 122h, the rest 
were inseparable from the unreacted alkynes. The absolute configurations of the 
allenes were determined as S by the Lowe-Brewster rule.16 
It was worthy to note that the bulky ester group was a prerequisite for the reaction 
to proceed in high ee. The allenoate 122p can be only achieved with 58% ee and 50% 
conversion detected by 1H NMR under the optimized conditions (Figure 2.2). 
Furthermore, the isomerization of alkyl alkynoates was too slow to be useful under 
current reaction conditions (Figure 2.1, entries 121n–o).  
 
Figure 2.2 Non efficient substrates for the isomerization of 3-alkynoates. a The 
conversion of 122p was determined by 1H NMR. b Chiral HPLC analysis. 
 5-Hydroxyallenoates are versatile synthetic intermediates and particularly 
suitable for electrophilic cyclization. 17  Propargylic alcohol 121i underwent the 
isomerization smoothly to give allene 122i in good conversion and high 
                                                        
16 (a) Lowe, G. Chem. Commun. 1965, 411–413. (b) Brewster, J. H. Top. Stereochem. 1967, 2, 1–72. 
17 (a) Ma, S.; Zhao, S. J. Am. Chem. Soc. 2001, 123, 5578–5579. (b) Hoffmann-Röder, A.; Krause, N. Org. Lett. 




enantioselectivity. Excellent ees were also achieved with a tertiary propargylic alcohol 
121j or O-benzyl (Bn) protected propargylic alcohol 121k (Scheme 2.11, 122j–k). It 
was interesting to note that N-phthalimido (PhthN) protected propargylic amine 121m 
gave much better conversion than the N-Carbobenzyloxy (N-Cbz) protected amine 
121l (Scheme 2.11, 122l–m). When rac-122m was subjected to the optimized reaction 
condition, no change in ee was observed. 
 
Scheme 2.11 Asymmetric synthesis of 5-functionalized allenoates 122i-m. a 
Conversion of 122 was determined by 1H NMR. b Chiral HPLC analysis. c 2 mol% of 
1b used. 
 




Scheme 2.12 Synthesis of sulfonyl alkyne 134 and its application in the 
enantioselective isomerization reaction. a The conversion of 135 was determined by 
1H NMR. b Chiral HPLC analysis. 
In order to test the proton transfer reaction on different types of substrates, we 
synthesized alkynes with different electron withdrawing group on the α-position, like 
129 and 130 (Figure 2.3).  Unfortunately, both of them did not give any 
corresponding allenes in the asymmetric isomerization conditions. We reasoned that 
the protons on the α-position were not acidic enough to be de-protonated by the 
bicyclic guanidine catalyst.  
Alternatively, a sulfonyl alkyne 134 was easily synthesized by a two step protocol 
with acceptable yields (Scheme 2.12). (3-Bromoprop-1-ynyl)benzene 131 was 
substituted by the specific thiol 132 under basic condition to give the thiol ether 133, 
the sulfonyl alkyne 134 was quickly achieved by the oxidation of the thiol ether 133 
using mCPBA. The sulfonyl alkyne 134 gave a moderate conversion (45%) but low 


























Figure 2.4 Asymmetric synthesis of allenic ketones 94 and 95a-b. a The conversion 
was determined by 1H NMR. b Chiral HPLC analysis. 
Subsequently, we developed two methods to prepare propargylic ketones (Scheme 
2.13). 2-(4-bromophenyl)oxirane 136 was opened by (phenylethynyl)lithium at the 
less hinder side to give propargylic alcohol 137 with 78% yield. propargylic ketone 
138 could be achieved by oxidation propargylic alcohol 137 with Dess-Martin reagent 
in 62% yield (Scheme 2.13, method A). The silica chromatography purification 
method can not be applied to the isolation of propargylic ketone 138 since it quickly 
converted to the corresponding allene with a large amount in the silica gel column. 
Instead, the reaction solution can be passed through a pad of celite which gave pure 
propargylic ketone 138. In our asymmetric isomerization condition, the propargylic 
ketone 138 gave the allenic ketone 142 with a high conversion (83%) but still low 
enantioselectivity (35% ee) (Figure 2.4). 
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In order to synthesize varies propargylic ketones, propargylic alcohol 139 were 
coupled with tert-butyl 2-diazoacetate 120 reported by Fu’s13 group to give interesting 
intermediates 140. Two propargylic ketones 141a and 141b were achieved with high 
yields (89% for 141a and 99% for 141b) using the same oxidation method as previous 
approach did (Scheme 2.13, method B). Undoubtedly, the allenic ketones 143 were 
achieved with high conversions (95% for 143a and 81% for 143b) but still low 
enantioselectivities (25% for 143a and 30% for 143b) (Figure 2.4). Unfortunately, the 
further optimization of the reaction conditions on these substrates did not improve the 
enantionselectivities. 
Thus, we have shown that 3-alkynoates gave axial chiral allenoates with high 
enantioselectivies in our novelty asymmetric isomerization conditions. However, 
other types of chiral allenes did not successfully prepared with high enantioselectivies 
in the asymmetric isomerization conditions. 
2.2.5 The relative stabilities between selected alkyne/allene isomer pairs 
 As we always achieved incomplete reactions, we were interested in the stablilities 
between alkynes and allenes. We utilized DFT calculations (B3LYP) method to 
evaluate the relative stabilities between selected alkyne/allene isomer pairs. In fact, all 
allenes evaluated were found to be more stable than the corresponding alkynes, since 
all of the ΔG values between the allenes and their corresponding alkynes are negative 
(Table 2.2). The calculated ΔG values correlate well with the observed yields. For 
example, the ΔG value between 122e and 121e was −4.3 kcal/mol, which was smaller 
than the value between 122f and 121f (−3.0 kcal/mol) (Table 2.2, entries 2–3). 
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Experimentally, we have found that 121e gave higher conversion (80%) to its 
corresponding allene than 121f did (39%). While all of the ΔG values were bigger 
than −3.0 kcal/mol, which suggest that all the isomerizations could go to high reaction 
conversion, prolonged reaction times must be required. With appropriate design of 
isomers pairs (ΔG values>6 kcal/mol), isomerization of synthetic value can be 
obtained. 
Table 2.2 Relative stabilities of alkyne/allene isomer pairs at −20 oC. 
 
entry 121 122 ΔH/kcal/mol ΔS/eu ΔG/kcal/mol conv./%a
1 121a 122a −5.1 −5.8 −3.7 70 
2 121e 122e −5.5 −5.0 −4.3 80 
3 121f 122f −4.6 −6.2 −3.0 39 
4 121m 122m −7.4 −3.4 −6.5 94 
a Isolated combined with 121 and 122; % of 122 is in parentheses and was determined 
by 1H NMR. 
2.2.6 Proposed stereochemical model for the origin of enantioselectivity 
 
Figure 2.5 Hydrogen bonding pattern between guanidinium groups and oxoanions 
revealed by crystal X-ray structures: I) guanidinium with phosphates; II) guanidinium 
with carboxylates; III) guanidinium with nitrates.  
In the chiral bicyclic guanidine catalyzed enantioselective isomerization of 
3-alkynoates, we believe that two key features of guanidine and guanidinium group 
are important: 1) the high basicity of the guanidine group is leading to initiate the 
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isomerization by generating the carbanion; 2) hydrogen bonds should be formed 
between the guanidinium group and oxoanions.  
The crystal structures of guanidinium groups with phosphates (I), carboxylates (II), 
or nitrates (III), have revealed the typical arrangement of hydrogen bonds to 
oxoanions (Figure 2.5).18 In all these three arrangements, a guanidinium-oxoanion 
complex was formed through double hydrogen bonding. The complexes were also 
























Scheme 2.14 Proposed catalytic cycle in the chiral bicyclic guanidine catalyzed 
isomerization of 3-alkynoates. 
Based on these observations and speculations, the catalytic cycle of the chiral 
bicyclic guanidine 1b catalyzed isomerization of 3-alkynoates was proposed in 
Scheme 2.14. In the first step of the cycle, deprotonation of 3-alkynoate 121a by 
chiral guanidine 1b generates a guanidinium cation and an enolate anion. The positive 
charge on the guanidinium is spread among the three nitrogens by resonance, with 
                                                        
18 Schmidtchen, F. P.; Berger, M. Chem. Rev. 1997, 97, 1609–1646.  
19 Bioorganic Chemistry Frontiers; Hannon, C. L., Anslyn, E. V., Eds.; Springer-Verlag: Berlin, Heidelberg, 1993, 
vol 3, 193.  
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two –NH groups as potential hydrogen bonding donors. An ion pair 
guanidinium-enolate complex 144 is presumably formed through hydrogen bonding, 
maintaining co-planarity between the guanidinium and the enolate. The enolate gains 
back a proton from the guanidinium ion to release the catalyst 1b and give the product 
122a as S configuration. 
The origin of the enantioselectivity lies in the selective approach of 121a to the 
well-defined guanidinium-enolate complex 144. Due to the steric repulsion by the 
proximal tert-butyl groups of the guanidinium, the tert-butyl group of the alkyne 
enolate is tilted away from the co-plane. The model A and C are favored in Scheme 
2.16, which give the product 122a as S configuration. This hypothesis is supported by 
the following observations: 
1) As we mentioned, the bulky ester group was a prerequisite for the reaction to 
proceed in high ee.  
2) The R group in 121 does not influence the enantioselectivities of the reaction 
significantly. 
In summary, we have proposed a reasonable stereochemical model for the origin 
of the enantioselectivity in the chiral bicyclic guanidine catalyzed isomerization of 
3-alkynoates. Further studies by other techniques, such as computational study, 
kinetic effect and crystal X-ray diffraction may give greater insights and help to 




Scheme 2.15 Proposed pre-transition-state assemblies for the chiral bicyclic 
guanidine catalyzed isomerization of 3-alkynoate 121a. 
2.3 Application and Chirality Transfer for Chiral 3-Allenoates 
2.3.1 Preparation of functionalized chiral β-halobutenolides from chiral 
3-allenoates 
 An important application of chiral allenes is the preparation of functionalized 
chiral lactones such as β-halobutenolides.20 Chiral allenoate 122g was selected to test 
these transformations since it was seperatable with alkynoate 121g by flash 
chromatography. The iodo-lactonization of allenoate 122g with N-iodosuccinimide 
(NIS) occurred at very mild conditions to give 145a with moderate yield (49%) and 
some loss of ee (75%) (Scheme 2.16, Eq. 1). While the bromo-lactonization of 
allenoate 122g with pyridinium tribromide (PyHBr3) occurred to give 
                                                        
20 (a) Ma, S.; Wu, S. Tetrahedron Lett. 2001, 42, 4075–4077. (b) Ma, S.; Wu, S. Chem. Commun. 2001, 441–442. 
(c) Font, J.; Gracia, A.; de March, P. Tetrahedron Lett. 1990, 31, 5517–5520. (d) Shingu, K.; Hagishita, S.; 
Nakagawa, M. Tetrahedron Lett. 1967, 8, 4371–4374. 
Chapter 2 
 52
β-bromobutenolide 145a with moderate 67% yield and 76% ee (Scheme 2.16, Eq. 2). 
When a mixture of 121b and 122b was cyclized with pyridinium tribromide (PyHBr3), 
good chirality transfer to 145b was observed with 60% yield and 86% ee and alkyne 
121b was recovered quantitatively (Scheme 2.16, Eq. 3).  
   We did not fully understand the details for the loss of ee in the 
3-allenoate-halobutenolide transformations. One possible reason was that some free 
halogen molecules might present in those reagents. The halogen molecules can react 
with allenes and partially destroyed the chirality of the allenes.   
 
Scheme 2.16 Preparation of functionalized chiral β-halobutenolides from chiral 
allenoates. 
 
Scheme 2.17 Preparation of functionalized chiral β-bromobutenolides 145d for 
determination of absolute configuration.  
The absolute configuration of β-bromobutenolide 145d was assigned as S by 
comparing the optical rotation value of 145d with the literature value (Scheme 
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2.17). 21  Lit. D][α : +149 (hexane), 26][ Dα : +32.0 (c 0.55, MeOH). Thus, we 
confirmed the absolute configuration of chiral allene 122 as S configuration, deducing 
from the absolute configuration of β-bromobutenolide 145. 
2.3.2 Cationic gold as catalyst for cyclization of allenoates 
 
Scheme 2.18 Cationic gold as catalyst for cyclization of allenoate 122m.  
 Cationic gold is an active catalyst in the activation of allenes.22 It was found that 
gold catalysts were efficient for cyclization of allenoates to get functionalized 
butenolides.22b, c When stoichiometric amount of Au(PPh3)Cl and AgOTf were used, 
chiral organogold(I) compound 146b (85% ee) along with varied amounts of 
hydrolyzed lactone 146a were obtained in combined yield of 97%. The ratio of 
146a:146b was dependent on the reaction time, ranging from 7:3 to 1:2. The chiral 
organogold compound 146b also decomposed slowly to lactone 146a at room 
temperature. They were inseparable by flash chromatography so the structure of 
lactone 146a was confirmed by hydrolyzing the gold complex 146b with 
toluenesulfonic acid in toluene at 65 °C. The enantioselectivity of lactone 146b was 
maintained. Based on the above observations, we envisioned that the cationic gold 
species will be released back to the system to complete a full catalytic cycle. Using 10 
                                                        
21 Shingu, K.; Hagishita, S.; Nakagawa, M. Tetrahedron Lett. 1967, 8, 4371–4374. 
22 Selected examples, see: (a) Hashmi, A. S. K.; Schwarz, L.; Choi, J.-H.; Frost, T. M. Angew. Chem. Int. Ed. 2006, 
45, 3314–3317. (b) Liu, L.-P.; Xu, B.; Mashuta, M. S.; Hammond, G. B. J. Am. Chem. Soc. 2008, 130, 
17642–17643. (c) Kang, J.-E.; Lee, E.-S.; Park, S.-I.; Shin, S. Tetrahedron Lett. 2005, 46, 7431–7433. (d) Zhang, 
Z.; Widenhoefer, R. A. Org. Lett. 2008, 10, 2079–2081. (e) Zhang, Z.; Bender, C. F.; Widenhoefer, R. A. J. Am. 
Chem. Soc. 2007, 129, 14148–14149. (f) Nishina, N.; Yamamoto, Y. Angew. Chem. Int. Ed. 2006, 45, 3314–3317. 
Chapter 2 
 54
mol % of Au(PPh3)Cl/AgOTf system, the chiral allene 122m along with small amount 
of 3-alkynoate 121m was converted to butenolide 146a with 81% yield and 86% ee. 
The chiral organogold(I) compound 146b was formed in 4% yield (Scheme 2.18). We 
were able to obtained the chiral organogold(I) compound 146b by the first time, 
which should be very important for the design of cationic gold catalyzed 
enantioselective reactions as well as the mechanism study of those reaction. 
2.3.3 Cycloadditions of allenoates with cyclopentadiene 
  
Scheme 2.19 Cycloadditions of allenoates with cyclopentadiene 147 to give the 
Diels-Alder adducts and recover the corresponding 3-alkynoates 121.  
Table 2.3 Cycloadditions of allenoates 122i and 122l-m with cyclopentadiene 147 to 
give the Diels-Alder adducts and recover the corresponding 3-alkynoates 121i and 
121l-m (Scheme 2.19). 
 
entry 122 (122:121, %ee of 122) yield/%a dr b ee/%c 
1 122i (57:43, 86) 85 (70) 4:1 85(148a), 89(149a) 
2 122l (65:35, 91) 98 (60) 3:1 87(148b), 85(149b) 
3 122m (94:6, 94) 99 (–) 2:1 93(148c), 93(149c) 
a Isolated yield based on amount of allene present; % recovery of 121 in parentheses. b 
Determined by 1H NMR.. c Chiral HPLC analysis. 
The cycloaddition of allenoates with dienes are of great interest to natural 
products chemists.23 The enantio-rich allenoates 122 and their corresponding non 
separated 121 were subject to the cycloaddition conditions. The Diels-Alder reaction 
between allenoates 122 and cyclopentadiene 147 gave the endo diastereomer 148 
(olefin in Z configuration) as the major isomer and exo diastereomer 149 as the minor 
                                                        
23 (a) Oppolzer, W.; Chapuis, C.; Dupuis, D.; Guo, M. Helv. Chim. Acta 1985, 68, 2100–2114. (b) Jung, M. E.; 
Nishimura, N. Org. Lett. 2001, 3, 2113–2115. (c) Gandhi, R. P.; Ishar, M. P. S.; Wali, A. J. Chem. Soc., Chem. 
Commun. 1988, 1074–1075. 
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isomer, which was also exist in Z configuration of the olefin (Scheme 2.19).  
When allenoate 122i (86% ee) with 43% alkynoate 121i was test, chiral 
Diels-Alder adduct 148a (85% ee) along with exo diastereomer 149a (89% ee) were 
obtained in combined yield of 85% and with a good d.r. ratio (4:1). At the meantime, 
we can recover most of the alkynoate 121i with 70% yield based on the amount of 
alkyne present (Table 2.3, entry 1). The chirality of the allenoate was efficiently 
transferred to the Diels-Alder adducts. Similarly, the allenoate containing amino 
group 122l (91% ee) with 35% alkynoate 121l can be transferred to the corresponding 
Diels-Alder adducts 148b (87% ee) and 149b (85% ee) in combined yield of 98% and 
with a good d.r. ratio (3:1). The alkynoate 121l was recovered in 60% yield (Table 2.3, 
entry 2). We can also achieve Diels-Alder adducts 148c (93% ee) and 149c (93% ee) 



























Figure 2.6 NOE experiments on the relative stereochemistry of the Diels-Alder 
adduct 148b and 149b. 
We have isolated 148b and 149b to determine the relative stereochemistry of the 
Diels-Alder adducts. NOE experiments (Figure 2.6) of the product obtained from 
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149b showed that there was obvious NOE (6.3%) between H3 and H4. It was 
obviously showed that the olefin existed in Z configuration. Moreover, the NOE 
(2.6%) between H5 and H6 and the NOE (5.1%) between H5 and H1 gave strong 
evidence to show that the minor compound 149b was the exo diastereomer. Instead, 
there was no NOE between H5 and H1 but slight NOE (1.8%) between H5 and H4 in 
148b, which indicated that the major compound 148b was the endo diastereomer. The 
Z configuration of olefin in endo diastereomer 148b has also been confirmed by the 
NOE (6.0%) between H3 and H4 (Figure 2.6). 
 
Figure 2.7 Proposed pathways for cycloadditions of 148 and 149. 
A model was proposed to determine the absolute stereochemistry of the 
cycloaddition products. Since the electronic density of the double bond next to the 
ester group is less than the outside one’s, the Diels-Alder reaction should happen to 
the inter olefin of the allenoate (Figure 2.7). Furthermore, the diene should approach 
the allenoate from the least hindered side. When the diene in cyclopentadiene 147 
faced out to attach the olefin, exo diastereomer 149 were achieved. One the other hand, 
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endo diastereomer 148 were achieved when the -CH2- in cyclopentadiene 147 faced 
out to attach the olefin (Figure 2.7). 
 In summary, chiral bicyclic guanidine 1b is found to catalyze the isomerization of 
alkynes to chiral allenes with high ees.24 The axial chirality is efficiently transferred 
to functionalized butenolides and cycloaddition products. We have also successfully 
demonstrated the stereospecific synthesis of butenolide through allenoate cyclization 
with catalytic cationic Au(I) complex. The mechanism for the isomerization has been 
proposed for further research.  
                                                        
24 Liu, H.; Leow, D.; Huang, K.-W.; Tan, C.-H. J. Am. Chem. Soc. 2009, 131, 7212–7213. The special thanks go to 















 Brønsted-Base Catalyzed Tandem 





3.1 Introduction to the Synthesis of 2-Alkylidenetetrahydrofurans 
3.1.1 The synthesis of 2-alkylidenetrahydrofurans in natural products 
 Oxacycles and azacycles are important heterocyclic systems which are commonly 
found in natural products and valuable fine chemicals.1 In particular, functionalized 
tetrahydropyrans and tetrahydrofurans are present in a variety of pharmacologically 
active natural products including annonaceous acetogenins and polyether antibiotics 
(Figure 3.1).2 The naturally occurring acetogenins have attracted increasing interest, 
which are known not only for their antitumor activity but also for being potent 
antimalarial, immunosuppressive, pesticidal and antifeedant agents.2a-c Relatively, 
polyether antibiotic natural products are challenge for synthesis, since they usually 
have several asymmetric centers which are present on the backbone of a number of 
carbon atoms.2d-i Meanwhile, the most important steps in the synthesis of these natural 
products are often the ring closure steps to obtain the tetrahydrofurans. Several 
syntheses have utilized 2-alkylidenetetrahydrofurans as the key intermediates.3 The 
reduction of 2-alkylidenetetrahydrofurans gave the corresponding tetrahydrofurans. 
                                                        
1 (a) Progress in Heterocyclic Chemistry; Suschitzky, H., Scriven, E. F. V., Eds.; Pergamon: Amsterdam, 1998; Vol. 
5–7. For reviews on oxacycles, see: (b) Yasumoto, T.; Murata, M. Chem. Rev. 1993, 93, 1897–1909. (c) Lee, E. 
Pure Appl. Chem. 2005, 77, 2073–2081. (d) Kang, E. J.; Lee E. Chem. Rev. 2005, 105, 4348–4378. For reviews on 
azacycles, see: (e) Boger, D. L.; Boyce, C. W.; Garbaccio, R. M.; Goldberg, J. A. Chem. Rev. 1997, 97, 787–828. (f) 
Katritzky, A. R.; Rachwal, S.; Rachwal, B. Tetrahedron 1996, 48, 15031–15070. (g) Sunderhaus, J. D.; Martin, S. 
F. Chem. Eur. J. 2009, 15, 1300–1308. 
2 (a) Keinan, E.; Sinha, S. C. Pure Appl. Chem. 2002, 74, 93–105. (b) Cecil, A. R. L.; Hu, Y.; Vicent, M. J.; 
Duncan, R.; Brown, R. C. D. J. Org. Chem. 2004, 69, 3368–3374. (c) Sinha, S. C.; Keinan, E. J. Am. Chem. Soc. 
1993, 115, 4891–4892. (d) Evans, D. A.; Ratz, A. M.; Huff, B. E.; Sheppard, G. S. Tetrahedron Lett. 1994, 35, 
7171–7172. (e) Evans, D. A.; Polniaszek, R. P.; DeVries, K. M.; Guinn, D. E.; Mathre, D. J. Am. Chem. Soc. 1991, 
113, 7613–7630. (f) Schmid, G.; Fukuyama, T.; Akasaka, K.; Kishi, Y. J. Am. Chem. Soc. 1979, 101, 259–260. (g) 
Nakata, T.; Schmid, G.; Vranesic, B.; Okigawa, M.; Smith-Palmer T.; Kishi, Y. J. Am. Chem. Soc. 1978, 100, 
2933–2935. (h) Ireland, R. E.; Anderson, R. C.; Badoud, R.; Fitzsimmons, B. J.; McGarvey, G. J.; Thaisrivongs, S.; 
Wilcox, C. S. J. Am. Chem. Soc. 1983, 105, 1988–2006. (i) Morimoto, Y.; Okita, T.; Kambara, H. Angew. Chem. 
Int. Ed. 2009, 48, 2538–2541. (j) Dohohoe T. J.; Butterworth, S. Angew. Chem. Int. Ed. 2005, 44, 4766–4768. 
3 For natural product synthesis using 2-alkylidenetetrahydrofuran as the key intermediate, see: (a) Bartlett, P. A.; 
Meadows, J. D.; Ottow, E. J. Am. Chem. Soc. 1984, 106, 5304–5311. (b) Lygo, B. Tetrahedron 1988, 44, 




Figure 3.1 Structures of natural products with functionalized tetrahydrofurans: 
acetogenins 150 and polyethers 151.  
3.1.2 Synthetic methods for 2-alkylidenetrahydrofurans 
 The multi-functionalities in 2-alkylidenetetrahydrofurans make them 
synthetically valuable. 4  Detty reported a practical method to prepare 
(acylmethylene)tetrahydrofurans 154 through the cyclization and condensation of 
6-hydroxy-1,3-hexanediones 152 (Scheme 3.1).4a When the 1,3-diketone compounds 
152 were treated with about 2 equivalents of triphenylphosphine either in CCl4 or in 
ether with 2 equivalents of CBr4, the dehydration products 106 were obtained in 













152 153 X=Cl or Br 154  
Scheme 3.1 The synthesis of 154 through the cyclization and condensation of 
6-hydroxy-1,3-hexanediones 152.  
 
Scheme 3.2 The synthesis of vinylogous carbonates 156 through Reformatsky 
reactions of thionolactones 155.  
Lee and co-workers used Reformatsky reactions between zinc enolate and 
                                                        
4 (a) Detty, M. R. J. Org. Chem. 1979, 44, 2073–2077. (b) Lee, H. K.; Kim, J.; Pak, C. S. Tetrahedron Lett. 1999, 
40, 6267–6270. (c) Gabriele, B.; Salerno, G.; Pascali, F. D.; Costa, M.; Chiusoli, G. P. J. Organomet. Chem. 2000, 
593−594, 409–415. (d) Kato, K.; Nishimura, A.; Yamamoto, Y.; Akita, H. Tetrahedron Lett. 2001, 42, 4203–4205. 
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thionolactone compounds to obtain these key intermediates (Scheme 3.2).4b This is a 
new and easy method for the synthesis of vinylogous carbonates 156 in good yields 
from the reaction of methyl bromozincacetate with various thionolactones 155, which 
are available from the corresponding lactones and Lawesson’s reagent.   
Another approach was described by both the groups of Gabriele and Kato, who 
obtained the intermediate using palladium-catalyzed oxidative 
cyclization-alkoxycarbonylation of alkynes.4c-d In Gabriele’s system, the reaction was 
performed under high pressure and temperature using a PdI2/KI catalyst, and afforded 
a mixture of the acetal products 158b and 158c by the generated acid-catalyzed 
addition of MeOH along with β–alkoxyacrylate 158a (Scheme 3.3, eq 1). To 
overcome this disadvantage, p-Benzoquinone was developed to be an efficient reagent 
for trapping a proton of hydrochloric acid arising from the catalytic cycle and 
oxidative transfer of the generated Pd(0) species to Pd(II) species. Therefore, Kato et 
al. successfully developed an improved method for the synthesis of 
(E)-cyclic-β-alkoxyacrylates 160 using a Pd(II)/ p-benzoquinone catalytic system 
under mild conditions (Scheme 3.3, eq 2).  
 
Scheme 3.3 The synthesis of the intermediates 158a and 160 using 




Scheme 3.4 The synthesis of the 2-alkylidene-tetrahydrofurans 162 and 165 utilizing 
one-pot cyclization reactions of 1,3-dicarbonyl dianions 161 or 1,3-bis-silyl enol 
ethers 164.  
More recently, Langer’s group prepared 2-alkylidene-tetrahydrofurans5 utilizing 
one-pot cyclization reactions of 1,3-dicarbonyl dianions or 1,3-bis-silyl enol ethers 
with 1,2-dielectrophiles. By treating the 1,3-dicarbonyl compound 161 with 2 
equivalents of LDA, “free dianions” were formed. These dianions can give the desired 
products 162 with special 1,2-dielectrophiles like 1-bromo-2-chloroethane (Scheme 
3.4, eq 1). It is surprising that the chloro group is compatible with the generation of 
the dianions and reduced the side reactions. On the other hand, 1,3-bis-silyl enol 
ethers (“mask dianions”) 164 prepared with a two step protocol can be utilized to 
synthesize 2-alkylidene-tetrahydrofurans 165 (Scheme 3.4, eq 2).6 It should be noted 
that proper adjustment of the temperature (stirring at −78 to 20 oC for 5h and 20 oC for 
12 h) and the choice of the Lewis acid (TiCl4, 2 eqiuv.) played important roles in the 
                                                        
5 Selected examples for cyclization of dianion with dielectrophiles, see: (a) Bellur, E.; Freifeld, I.; Böttcher, D.; 
Bornscheuer, U. T.; Langer, P. Tetrahedron 2006, 62, 7132–7139. (b) Bellur E., Langer, P. J. Org. Chem. 2005, 70, 
10013–10029. (c) Bellur, E.; Görls, H.; Langer, P. Eur. J. Org. Chem. 2005, 10, 2074–2090. (d) Bellur, E.; Freifeld, 
I.; Langer, P. Tetrahedron Lett. 2005, 46, 2185–2187. (e) Langer, P.; Bellur, E. J. Org. Chem. 2003, 68, 9742–9746. 
(f) Langer, P.; Armbrust, H.; Eckardt , T.; Magull, J. Chem. Eur. J. 2002, 8, 1443–1455. (g) Langer, P. Krummel, T. 
Chem. Eur. J. 2001, 7, 1720–1727. (h) Langer, P.; Freifeld, I. Chem. Eur. J. 2001, 7, 565–572. (i) Langer, P.; Holtz, 
E.; Karim, I.; Saleh, N. N. R. J. Org. Chem. 2001, 66, 6057–6063. (j) Freifeld, I.; Holtz, E.; Dahmann, G.; Langer, 
P. Eur. J. Org. Chem. 2006, 14, 3251–3258. 
6 (a) Chan, T.-H.; Brownbridge, P. J. Am. Chem. Soc. 1980, 102, 3534–3538. (b) Molander, G. A.; Cameron, K. O. 
J. Am. Chem. Soc. 1993, 115, 830–846. 
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success of the reaction. Several other methods were also reported but they would 
require harsher conditions.7 
2-Alkylidenetetrahydrofurans are very important intermediates in the synthesis of 
various types of natural products. Only a few methods have been reported to prepare 
2-alkylidenetetrahydrofurans. Furthermore, most of them require harsh conditions or 
two step protocols. To date, no successful example was presented by using 
organocatalysts.  
Intramolecular oxy- and aza-Michael reactions has also became important 
strategies to prepare oxacycles and azacycles.8 Activated alkenes have been widely 
used as Michael acceptors.8a Base-promoted intramolecular oxy-Michael reaction of 
electron deficient allenes have been shown to undergo cyclization via the 
endo-mode.8b As a result of our previous work in Chapter 2, we became interested in 
the development of intramolecular hetero-Michael reactions that utilized the allenes 
generated in situ by the Brønsted base-catalyzed isomerization of alkynes.  
3.2 Brønsted-Base Catalyzed Tandem Isomerization-oxy-Michael 
Reactions of Alkynes: a Novel Method for Synthesis of 
2-Alkylidenetetrahydrofurans 
3.2.1 Synthesis of 3-alkynoates 
 In Chapter 2, when we explained our works on enantioselective isomerization of 
                                                        
7 (a) Krueger, S. A.; Bryson, T. A. J. Org. Chem., 1974, 39, 3167–3168. (b) Pflieger, D.; Muckensturm, B. 
Tetrahedron 1989, 45, 2031–2040. (c) Edwards, G. L.; Sinclair, D. J. Tetrahedron Lett. 1999, 40, 3933–3934. 
8 For reviews on intramolecular Michael additions, see: (a) Little, R. D.; Masjedizadeh, M. R. Org. React. 1995, 
47, 315–552. For allenes as acceptors, see: (b) Kitagaki, S.; Kawamura, T.; Shibata, D.; Mukai, C. Tetrahedron 
2008, 64, 11086–11095, and references therein. 
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3-alkynoates,9  we introduced a method to prepare ketone type alkynes 141a-b 
(Scheme 2.13). In the meantime, interesting intermediates 140 were achieved without 
any corresponding allenes using Fu’s method via copper(I) catalyzed C-C coupling 
between terminal alkynes 139 and diazo compounds 113 and 120 (Scheme 3.5).10 
Therefore, little effort was needed to get pure 6-hydroxy-3-alkynoates 140 for testing 
the Brønsted-base catalyzed tandem isomerization-oxy-Michael reaction.  
 
Scheme 3.5 Standard synthesis of 6-hydroxy-3-alkynoates 140.  
3.2.2 Optimization studies on tandem isomerization-oxy-Michael reaction 
When 6-hydroxyalkynoate 140a was subjected to the isomerization-oxy-Michael 
condition with 1 equivalent of triethylamine (Table 3.1, entry 1), two unusual 
cyclization products 165a and 166 were obtained together with a small amount of 
allene 167 detected by 1HNMR. Next, we investigated the effects of using different 
bases, like pyridine, 1,4-diazabicyclo[2.2.2]octane (DABCO) and 
1,8-diazabicylo[5.4.0] undec-7-ene (DBU) (entries 2-5). No products were observed 
when pyridine was used as the catalyst and the use of DABCO resulted in only 40% 
conversion. Complete reaction was observed with 10 mol% of DBU, 10 mol% of 
1,3,4,6,7,8-hexahydro-1-methyl-2H-pyrimido[1,2-α]pyrimidine (mTBD) or 10 mol% 
1,5,7-triazabicyclo[4.4.0]dec-1-ene (TBD). This is most likely due to their higher 
basicities. While complete reaction was observed for these three bases, the product 
                                                        
9 Liu, H.; Leow, D.; Huang, K.-W.; Tan, C.-H. J. Am. Chem. Soc. 2009, 131, 7212–7213. 
10 Suárez, A.; Fu, G. C. Angew. Chem. Int. Ed. 2004, 43, 3580–3582. 
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distribution was different (entries 4-6). Highest amount of 2-alkylidene 
tetrahydrofuran 165a was obtained using mTBD and TBD. The reaction using TBD as 
catalyst, which is a proven strong organobase,11 was the fastest and completed in 0.5 
hour. It was also found that different solvents such as THF and toluene resulted in 
different distribution of products. 
 
Scheme 3.6 Brønsted-base catalyzed tandem isomerization-oxy-Michael reaction of 
6-hydroxy-3-alkynoate 140a in different conditions. 
Table 3.1 Optimization on tandem isomerization-oxy-Michael reaction of 
6-hydroxy-3-alkynoate 140a in different conditions (Scheme 3.6). 
 
entry base solvent time/hr conv./% (165a : 166 : 167)a
1 Et3N a CH2Cl2 22 72 (7 : 33 : 60) 
2 Pyridine CH2Cl2 18 0 
3 DABCO CH2Cl2 18 40 (35 : 17 : 48) 
4 DBU CH2Cl2 1.5 100 (2 : 1: 0) 
5 mTBD CH2Cl2 2.5 100 (96: 4 : 0) 
6 TBD CH2Cl2 0.5 100 (100 : 0 : 0) 
7 TBD THF 2.5 100 (55 : 20 : 25) 
8 TBD Toluene 2.5 100 (84 : 16 : 0) 
a Conversion and the ratio of 165a, 166 and 167 were determined by 1HNMR. b 
1equivalent base used. 
3.2.3 The substrate scope for the tandem isomerization-oxy-Michael reaction  
A series of 6-hydroxyalkynoates 140a-g were prepared and subjected to the 
conditions for the tandem isomerization-conjugate addition reaction (Scheme 3.7). We 
firstly tested the aliphatic 6-hydroxy-3-alkynoates 140a and 140c; excellent isolated 
                                                        
11 (a) Ye, W.; Xu, J.; Tan, C.-T.; Tan, C.-H. Tetrahedron Lett. 2005, 46, 6875–6878. (b) Jiang, Z.; Zhang, Y.; Ye, W.; 
Tan, C.-H. Tetrahedron Lett. 2007, 48, 51–54. 
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yields of 165a (94%) and 165c (92%) were achieved and only the E diastereoisomers 
were observed.5i For non substituted 6-hydroxy-3-alkynoates 140d, (E)-tert-butyl 
2-(dihydrofuran-2(3H)-ylidene)acetate 165d was obtained with 82% yield. 
Interestingly, the aromatic 6-hydroxy-3-alkynoates 140b and 140d can also give the 
corresponding 2-alkylidenetrahydrofurans 165b and 165d with 92% and 94% yields. 
Moreover, a highly functionalized 2-alkylidenetrahydrofuran 165g was synthesized 
using our strategy with 92% yield. For all reactions, no dimer or oligomer was 
detected as a result of inter-oxy-Michael addition, and no interesterification product 






























94% yield 92% yield 92% yield
82% yield 89% yield





Scheme 3.7 Brønsted-base catalyzed tandem isomerization-oxy-Michael reaction for 
synthesis of 2-alkylidene-tetrahydrofurans 165. a Isolated yield.  
Other than the synthesis of 2-alkylidenetrahydrofurans, we were interested in 
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developing our tandem isomerization-oxy-Michael reaction to prepare oxacycles with 
different ring sizes. 5-Hydroxy-3-alkynoate 121i and 7-hydroxy-3-alkynoate 140h 
were prepared and subjected to the conditions in Scheme 3.7. We can only obtain the 
corresponding allene products with moderate yields (Figure 3.2). No cyclization 
product was observed for both examples.  
 
Figure 3.2 Non applicable substrate for the tandem isomerization-oxy-Michael 
reaction.  
3.2.4 Proposed mechanism for the tandem isomerization-oxy-Michael reaction 
In the tandem isomerization-oxy-Michael reaction, we speculated that allene 167 
is the common intermediate to both 165a and 166; and 166 can be isomerized to 165a 
under strongly basic conditions. We isolated allene 167 and tetrahydrofuran 166 
separately and subjected each of them to reaction conditions similar with 10 mol% 
TBD. In each case, both allene 167 and tetrahydrofuran 166 were fully converted to 
2-alkylidene-tetrahydrofurans 165a. When a mixture of allene 167 and 
tetrahydrofuran 166 was subjected to the reaction conditions, we could also obtain 
2-alkylidene-tetrahydrofurans 165a as a single product. Therefore, based on these 
observations and speculations, the catalytic cycle of the Brønsted base catalyzed 
tandem isomerization-oxy-Michael of 6-hydroxy-3-alkynoates 140 for the formation 
of 2-alkylidenetetrahydrofurans 165 was proposed in Scheme 3.8. 
6-Hydroxyalkynoate 140a first underwent the isomerization process to provide 
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6-hydroxyallenoate 167, followed by an intramolecular Michael addition to give a 
cyclized product 166. A similar process was reported by Mukai for the base-promoted 
oxacycle formation by endo-mode ring-closing reaction of allenes.8b Due to the 
acidity of the α-carbonyl proton, 166 was quickly isomerized to the thermodyamically 
more stable α,β-unsaturated ester, 2-alkylidenetetrahydrofuran 165a.  
 
Scheme 3.8 Proposed mechanism in tandem isomerization-oxy-Michael reaction of 
6-hydroxy-3-alkynoate 140a.  
3.2.5 Reduction of 2-alkylidenetetrahydrofurans  
 
Scheme 3.9 Reduction of 2-alkylidenetetrahydrofurans. 
To make our method more synthetic valuable, we are keen to develop approaches 
on the reduction of 2-alkylidenetetrahydrofurans to tetrahydrofurans.  It was reported 
that 5-alkyl substituted 2-alkylidenetetrahydrofurans can be easily reduced to their 
corresponding (tetrahydrofuran-2-yl)acetates with good diastereoselectivity under 
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Pd/C hydrogenation conditions.5a, 5j However, when 2-arylidenetetrahydrofuran 140e 
was subjected to the same Pd/C hydrogenation condition for 43 hours in MeOH, ethyl 
3-oxo-6-phenylhexanoate 168, a ring expanded keto-ester was obtained instead and 
with excellent yield (97%) (Scheme 3.9, eq 1). This is a new and easy approach to 
synthesize keto-ester compounds. Thus, a different reduction method was required 
and different hydride sources were examined for the reduction. Only Lewis 
acid-promoted silane reduction gave the functionalized tetrahydrofuran 169 with 98% 
yield (Scheme 3.9, eq 2). Attempts at improving the diastereoselectivity were not 
successful. Other hydride sources like NaBH4 gave a mixture of keto-ester 168 and 
tetrahydrofuran 169. 
3.3 Brønsted-Base Catalyzed Tandem Isomerization-aza-Michael 
Reactions of Alkynes: The Synthesis of Azacycles 
3.3.1 Brønsted-base catalyzed tandem isomerization-aza-Michael reaction of 
alkynyl-amines 
  
Scheme 3.10 Brønsted-base catalyzed tandem isomerization-aza-Michael reaction of 




We were interested to extend the concept of tandem isomerization-Michael 
reaction to accept other nucleophiles, in particular, nitrogen nuclephiles. 
Alkynyl-amines 170 were prepared and subjected to the optimized conditions 
(Scheme 3.10). Slightly longer reaction time (24 hours) was used to make sure that 
completed reactions were achieved as the products 171a-c were non-separable from 
their corresponding alkynyl-amines 170. Piperidine derivatives 171 were achieved in 
good yields.  
Since alkynyl-amine 170 have amine group as base in the molecules, other 
reaction pathways might be happened. For better understanding of the reaction, we 
subjected alkynyl-amine 170 to the same reaction conditions in Scheme 3.10 for one 
day without the presence of the base, TBD. Starting material was fully recovered and 
no other product was obtained. Therefore, the self-catalyzed reaction mechanism was 
excluded. We believe that the tandem isomerization-aza-Michael reactions undergo 
the similar pathways as we proposed in Scheme 3.8. 
3.3.2 Brønsted-base catalyzed tandem isomerization-aza-Michael reaction of 
alkynyl-amide 
 
Scheme 3.11 Preparation of alkynyl-amide 123. 
Other than using amine as the nucleophile, we were also interested to test amide 
as nucleophile in the tandem isomerization-aza-Michael reaction. Starting from 
commercially available pent-4-ynoic acid 172, N-phenylpent-4-ynamide 173 was 
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achieved with 75% yield via DCC/HOBt coupling reaction (Scheme 3.11). 
Subsequently, the desired compound ethyl 7-oxo-7-(phenylamino)hept-3-ynoate 174 
was obtained using Fu’s method9 from N-phenylpent-4-ynamide 173 with 90% yield. 
By subjecting the alkynyl-amide 174 to the optimized condition in Table 3.1, Lactam 





CH2Cl2 (0.1M), 18h, rt




174 175 96% yield  
Scheme 3.12 Isomerization-aza-Michael reaction of alkynyl-amide 123. 
3.3.3 Brønsted-base catalyzed tandem isomerization-aza-Michael reaction of 
alkynyl-carbamates 
Alkynyl-carbamate 177 can be derived from 5-hydroxyalkynoate 121i (Scheme 
3.13). By stirring 5-hydroxyalkynoate 121i with 1-fluoro-3-isocyanatobenzene 176 at 
room temperature in CH2Cl2 for 2 days, we can isolate the alkynyl-carbamate 177 
with a small amount of its corresponding allene in 86% combined yield. Subsequently, 
the alkynyl-carbamate 177 underwent tandem isomerization-aza-Michael reaction to 
give a 6-membered oxazolidinone 178 in 50% yield (Scheme 3.14). However, a 
significant amount of a side product (49% yield) was obtained and determined to be a 
conjugated imide 179 by the assignment of crude 1H NMR. Unfortunately, we were 
not successful for improving the ratio between the oxazolidinone 178 and the imide 




Scheme 3.13 Preparation of alkynyl-carbamate 177. 
 










































Scheme 3.15 Proposed mechanism in the formation of oxazolidinone 178 and imide 
179. 
Based on our speculations, the catalytic cycle of the Brønsted base catalyzed 
tandem isomerisation-aza-Michael of alkynyl-carbamate 177 for the formation of 
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oxazolidinone 127 and imide 128 was proposed in Scheme 3.15. Alkynyl-carbamate 
177 first underwent the isomerization process to provide carbamate-allenoate 180, 
followed by an intramolecular Michael addition to give a cyclized product 181. Due 
to the acidity of the α-carbonyl proton, the Brønsted base can easily extract the proton. 
Oxazolidinone 178 was formed through an isomerization process via pathway A. At 
the same time, imide 179 was formed through an elimination-decarboxylation process 
via pathway B. Since the rates of these two pathways were almost the same on 
different conditions, we were always obtained the oxazolidinone 178 and the imide 
179 with 1:1 ratio.  
3.3.4 Bicyclic guanidine catalyzed enantioselective tandem 
isomerization-aza-Michael reaction 
 
Scheme 3.16 Bicyclic guanidine catalyzed enantioselective tandem 
isomerization-aza-Michael reaction.  a Isolated yield. b HPLC analysis. 
 Based on our discovery of the tandem isomerization-aza-Michael reaction, we 
were keen to develop the asymmetric version of this reaction by utilizing bicyclic 
guanidine 1b as the chiral catalyst. An interesting substrate, alkynyl-amide 182, was 
synthesized by using the same method for the preparation of alkynyl-amide 174 as 
shown in Scheme 3.11. By stirring alkynyl-amide 182 with catalytic amount of 
bicyclic guanidine 1b (10 mol %) in CH2Cl2 for 4 days at room temperature, a full 
conversion reaction was detected by TLC. Two cyclized products were detected, 
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which were assigned as 183 and 184 by 1HNMR. The ratio between 183 and 184 on 
TLC was about 4:1. Subsequently, by passing the reaction mixture through a silica gel 
column slowly, cyclic compound 183 can be fully converted to lactam 184 with 60% 
ee (Scheme 3.16). Comparing to cyclic compound 183, high functionalized lactam 
184 is a more stable and higher conjugation compound. It also has an interesting axial 
chiral center. This axial chiral lactam 184 is potentially useful intermediate in organic 
synthesis. Further research, like optimization and substrate scope exploration of 
asymmetric tandem isomerization-aza-Michael reaction, is still on going. 
3.4 Unsuccessful Concepts for Brønsted-Base Catalyzed Tandem 
Isomerization-Michael Reactions 
3.4.1 Unsuccessful nucleophiles for tandem isomerization-Michael reaction  
OH




CuI (5 mol %)





























Scheme 3.17 Preparation of 3-alkynoates 187 and 189 with carbon nucleophiles.  
Other than oxygen and nitrogen nucleophiles, we would like to test carbon 
nucleophiles for tandem isomerization-Michael reaction. The terminal alkyne 
intermediate 186 was obtained by protecting the commercially available propargylic 
alcohol 119j with acetyl chloride 185. With the further coupling with tert-butyl 
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2-diazoacetate 120, we can quickly obtain the 3-alkynoate 187 with relative low yield 
(Scheme 3.17, method A). Alternatively, by opening 
2,2,6-trimethyl-4H-1,3-dioxin-4-one 188 with 5-hydroxy-3-alkynoate 121i, we can 
quickly obtain the 3-alkynoate 189 with 79% yield (Scheme 3.17, method B). 
Unfortunately, we can not achieve any tandem isomerization-Michael reaction 
product but their corresponding allenes for both of the substrates in the base 
conditions. 
3.4.2 Attempts on other type of tandem isomerization-Michael reaction  
Based on the mechanism of the tandem isomerization-Michael reaction, we 
believed that the allenic anion was formed in the first isomerization step (Scheme 3.9). 
We were interested in trapping the allenic anion to do an intramolecular Michael 
reaction. Thus, a special 3-alkynoate 190 was synthesized to test our idea by using the 
same protocol to prepare substrate 187 (Scheme 3.18, method A). The special allene 
192 might be achieved if the reaction underwent our desired reaction pathway 
(Scheme 3.18). However, our experiments showed that only the isomerization product 
191 can be achieved without any isomerization-Michael addition product 192 in 
different base conditions. 
 




In summary, we have discovered unusual Brønsted-base catalyzed tandem 
isomerization-Michael reactions under very mild conditions. 12  Functionalized 
2-alkylidenetetrahydrofurans with good to excellent yields were prepared by 
intramolecular oxy-Michael reaction on an allene that was generated in situ from 
alkynoate. The aza-Michael version using alkynyl-amines, alkynyl-amides and 
alkynyl-carbamates led to piperidines, lactams and oxazolidinones respectively. We 
have also proved the possibilities for bicyclic guanidine 1b catalyzed enantioselective 
tandem isomerization-aza-Michael reaction to synthesize axial chiral lactam 184. 
However, other applications were not successful. The mechanism for the 
isomerisation-oxy-Michael reaction has been proposed for further research.  
                                                        














 Bicyclic Guanidine Catalyzed Asymmetric 





4.1 Discovery of Tandem Mannich-Isomerization Reactions 
Our group previously reported that itaconimides 194 were good acceptors for 
asymmetric protonation reactions.1 In a few cases, we obtained a small amount of 
side products in the base condition. The side products were characterized as 
maleimide derivatives like 196a. Thus, we believed that the side products came from 
the isomerization of itaconimides 194 in the basic condition. We are keen to develop 
Brønsted base catalyzed novel asymmetric reactions using itaconimides 194 as donors. 
We have tested various types of Brønsted base catalyzed novel reactions between 
itaconimide 193a and different electrophiles. Unfortunately, we always obtained the 
isomerization product 196a without any desired product.  
 
Scheme 4.1 Discovery of tandem Mannich-isomerization reaction between imine 
193a and itaconimide 194a. a The conversion and the ratio between 195a and 196a 
were determined by TLC. 
With great effort, we treated itaconimide 194a with imine 193a in 10 mol % of 
1-methylpyrrolidine, we achieved an interesting product 195a along with the 
isomerized product 196a (Scheme 4.1). In order to figure out the pathway to the 
formation of the interesting product 195a, we proposed a possible mechanism for this 
reaction (Scheme 4.2). In the presence of base, itaconimide 194a was quickly 
deprotonated to form the dienolate 197a. The self-protonation of dienolate 197a 
                                                        
1 Leow, D.; Lin, S.; Chittimalla, S. K.; Fu, X.; Tan, C.-H. Angew. Chem. Int. Ed. 2008, 47, 5641–5645.  
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would give the corresponding isomerized product 196a. In contrast, the dienolate 
197a would react with imine 193a at the α- and/or γ- position, complex 197b was 
achieved by the Mannich reaction between dienolate 197a and imine 193a. With an 
isomerization process, we can get the intermediate 197c, which quickly converts to 
the product 195a as an α-adduct via a dynamic kinetic transformation process. The 
catalyst was released to complete the catalytic cycle. It was noteworthy that we did 
not obtain any γ-adduct 197d of the Mannich reaction in all cases. A similar dynamic 
kinetic transformation involving Ba-catalyzed direct aldol reaction was reported.2 























































Scheme 4.2 Proposed catalytic cycle for tandem Mannich-isomerization reaction 
between imine 193a and itaconimide 194a.  
Organocatalytic asymmetric Mannich reaction is a power transformation to access 
chiral amine-containing building blocks, which could be applied to the synthesis of 
                                                        
2 Yamaguchi, A.; Matsunaga, S.; Shibasaki, M. J. Am. Chem. Soc. 2009, 131, 10842–10843.  
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natural products and medicinal chemistry.3 Among all of them, guanidine catalyzed 
asymmetric Mannich reactions are relatively less reported.3k-l We have successfully 
synthesized α-fluorinated β-amino acid derivatives by applying the bicyclic guanidine 
catalyst 1b in the asymmetric Mannich reaction.3l Thus, we would like to develop a 
guanidine catalyzed asymmetric Mannich-isomerization reaction with high 
chemoslectivity and enantioselectivity.  
4.2 Development of Enantioselective Tandem Mannich-Isomerization 
Reactions 
4.2.1 Enantioselective tandem Mannich-isomerization reactions between 












193a 194a 195a 71% yield,a 30% eeb








Scheme 4.3 Bicyclic guanidine 1b catalyzed enantioselective tandem 
Mannich-isomerization reaction between imine 193a and itaconimide 194a. a Isolated 
yield. b Chiral HPLC analysis. 
By screening different types of chiral Brønsted base catalysts, we found that 
bicyclic guanidine 1b was an efficient catalyst for this reaction, giving the product 
195a with 30% ee and 71% yield. No isomerization product 196a was detected in the 
reaction conditions (Scheme 4.3).  
                                                        
3 For reviews, see: (a) Ting, A.; Schaus, S. E. Eur. J. Org. Chem. 2007, 5797–5815. (b) Verkade, J. M. M.; van 
Hermert, L. J. C.; Quaedflieg, P. J. L. M.; Rutjes, F. P. J. T. Chem. Soc. Rev. 2008, 37, 29–41. For selected 
examples, see: (c) Uraguchi, D.; Terada, M. J. Am. Chem. Soc. 2004, 126, 5356–5357. (d) Lou, S.; Taoka, B. M.; 
Ting, A.; Schaus, S. E. J. Am. Chem. Soc. 2005, 127, 11256–11257. (e) Tillman, A. L.; Ye, J.; Dixon, D. J. Chem. 
Commun. 2006, 1191–1193. (f) Song, J.; Wang, Y.; Deng, L. J. Am. Chem. Soc. 2006, 128, 6048–6049. (g) Yang, J. 
W.; Chandler, C.; Stadler, M.; Kampen, D.; List, B. Nature 2008, 252, 453–455. (h) Poulsen, T. B.; Alemparte, C.; 
Saaby, S.; Bella, M.; Jørgensen, K. A. Angew. Chem. Int. Ed. 2005, 44, 2896–2899. (i) Zhang, H.; Mifsud, M.; 
Tanaka, F.; Barbas III, C. F. J. Am. Chem. Soc. 2006, 128, 9630–9631. (j) Uraguchi, D.; Ueki, Y.; Ooi, T. J. Am. 
Chem. Soc. 2008, 130, 14088–14089. (k) Kobayashi, S.; Yazaki, R.; Seki, K.; Yamashita, Y. Angew. Chem. Int. Ed. 
2008, 47, 5613–5615. (l) Pan, Y.; Zhao, Y.; Ma, T.; Yang, Y.; Liu, H.; Jiang, Z.; Tan, C.-H. Chem. Eur. J. Chem. Eur. 





























































Scheme 4.4 Enantioselective tandem Mannich-isomerization reaction between 
itaconimide 194a and different imines. a Chiral HPLC analysis. b CHCl3 as solvent, 
low conversion by TLC. 
With our initial results, we have tested different types of N-tosylated type imines 
for the asymmetric Mannich-isomerization reactions (Scheme 4.4, 193a-d). These 
reactions can be completed in a short time but gave low to moderate ee values. 
Subsequently, Cbz and Boc protected imines were also subjected to the condition 
which interestingly gave higher ee values (Scheme 4.4, 193e-f). Thus, we developed 
new strategies to easily prepare various types of Boc protected imines 193f-h starting 
from the corresponding commercial available alcohols (Scheme 4.5).3l We were 
pleased to find that the R group in the protecting groups made great effect on the 
enantioselectivities (Scheme 4.4, 193f-h). By changing N-Boc imine 193f to 
N-ethoxycarbonyl (N-Eoc) imine 193h, the enantioselectivies were significantly 
improved. We speculated that the N-Eoc group gave higher stero-effect with the 
catalyst than that of the N-Boc group. Furthermore, we have successfully applied our 
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N-Eoc protection group to other enantioselective reactions.3l  
 
Scheme 4.5 Synthesis of Boc type imines 193f-g.  
4.2.2 Solvent effect on enantioselective tandem Mannich-isomerization reaction 
 
Scheme 4.6 Bicyclic guanidine catalyzed Mannich-isomerization reaction between 
N-Boc imine 193f and itaconimide 194a in different conditions. 
Table 4.1 Optimization on Mannich-isomerization reaction between N-Boc imine 
193f and itaconimide 194a in different conditions (Scheme 4.6). 
 
entry solvent time/hr conv./%a ee/%b 
1 Toluene 72 25 68 
2 THF 72 80 55 
3 Et2O 72 90 66 
4 CH2Cl2 60 100 73 
5 CHCl3 72 90 73 
6 Chlorobenzene 48 100 65 
7 ClCH2CH2Cl 29 100 65 
a Conversions were determined by TLC. b Chiral HPLC analysis. 
Since the N-Boc type imines gave better results than the N-tosylated type imines, 
we utilized N-Boc imine 193f to test the solvent effect on the enantioselective 
Mannich-isomerization reaction (Scheme 4.6). Common solvents including toluene, 
THF and Et2O were tested. CH2Cl2 gave the highest enantioselectivities with 73% ee 
(Table 4.1, entries 1-4). Subsequently, a series of chlorinated solvent were subjected 
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to test and CHCl3 gave the same level of enantioselectivities as CH2Cl2 did (Table 4.1, 
entries 4-7). However, changing the temperature and concentration did not improve 
the ees. 
4.2.3 Reaction scope of enantioselective tandem Mannich-isomerization reaction 
 
Scheme 4.7 Enantioselective tandem Mannich-isomerization reaction between N-Eoc 
imine 193h and itaconimides 194.  a Conversions were determined by TLC, % of 196 
is in parentheses. b Chiral HPLC analysis. c Isolated yield. 
With our optimized conditions, we screened different itaconimides for the 
enantioselective Mannich-isomerization reaction. However, only the N-aryl 
itaconimides with electron-withdrawing groups worked well (Scheme 4.7). The more 
electron deficient the itaconimides, the faster the speed of the reaction. Good 
enantioselectivities were achieved for all the substrates. We also tested a few N-Eoc 
aromatic imines 199 with itaconimide 194d for the tandem Mannich-isomerization 
reaction, which gave good ees (Scheme 4.8). The electron-rich aromatic imines 
199b-c gave a small portion of the isomerization product 196d.  
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Furthermore, a more specific itaconimide 201 was applied to the 
Mannich-isomerization reaction, which gave the corresponding product 202 with 87% 
yield but no ee value was observed (Scheme 4.9). 
 
Scheme 4.8 Enantioselective tandem Mannich-isomerization reaction between N-Eoc 
imines 199 and itaconimide 194d.  a Conversions were determined by TLC, % of 














202a, b 87% yield, 0% ee






CH2Cl2 (0.1M), rt, 12h
193a 201  
Scheme 4.9 Enantioselective tandem Mannich-isomerization reaction between N-Ts 
imine 193a and itaconimide 201.  a Isolated yield. b Chiral HPLC analysis.  
In conclusion, we have developed enantioselective tandem Mannich-isomerization 
reaction between imines and itaconimides catalyzed by a chiral bicyclic guanidine.4 
Moderate to good ees were achieved. However, the reaction scope was quite limited. 
Further research is still ongoing the extension and application of this reaction. 
                                                        




















5.1 General Information 
5.1.1 General procedures and methods 
Experiments involving moisture and/or air sensitive components were performed 
under a positive pressure of nitrogen in oven-dried glassware equipped with a rubber 
septum inlet. Air sensitive reagents were weighed in a glovebox. Dried solvents and 
liquid reagents were transferred by oven-dried syringes or hypodermic syringe cooled 
to ambient temperature in a desiccator. Reactions mixtures were stirred in 50 mL 
round bottle flasks or test tubes with Teflon-coated magnetic stirring bars unless 
otherwise stated. Moisture in non-volatile reagents/compounds was removed in high 
vacuo by means of an oil pump and subsequent purging with nitrogen. Solvents were 
removed in vacuo under ~30 mmHg and heated with a water bath at 33 °C using 
Heidolph or Büchi rotary evaporator with Eyela A-3S aspirator. The condenser was 
cooled with running water at 0 °C. 
Reactions requiring temperatures −20 °C were stirred in either Thermo Neslab 
CB-60 with Cryotrol temperature controller or Eyela PSL-1400 with digital 
temperature controller cryobaths. HPLC grade isopropanol was used as the bath 
medium.  
All experiments were monitored by analytical thin layer chromatography (TLC). 
TLC was performed on pre-coated plates, Merck 60 F254. After elution, plate was 
visualized under UV illumination at 254 nm for UV active material. Further 
visualization was achieved by staining KMnO4, ceric molybdate, or anisaldehyde 
solution. For those using the aqueous stains, the TLC plates were heated on a hot 
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plate.     
Columns for flash chromatography (FC) contained silica gel 60 (0.040 mm - 
0.063 mm, Merck). Columns were packed as slurry of silica gel in hexane and 
equilibrated with the appropriate solvent/solvent mixture prior to use. The analyte was 
loaded neat or as a concentrated solution using the appropriate solvent system. The 
elution was assisted by applying pressure of about 2 atm with an air pump. 
 
5.1.2 Instrumentations 
Proton nuclear magnetic resonance (1H NMR), carbon NMR (13C NMR), 
phosphorous NMR (31P NMR), and fluorine NMR (19F NMR) spectra were recorded 
in CDCl3 otherwise stated. 1H (500 MHz or 300 MHz), 13C (125 MHz or 75 MHz) 
with complete proton decoupling, 31P (202 MHz) with complete proton decoupling, 
and 1H Nuclear Overhauser Effect (NOE) NMRs were performed on a 500 MHz 
Bruker AMX NMR spectrometer. 19F NMR (282 MHz) was performed on a 300 MHz 
Bruker ACF spectrometer. Chemical shifts were reported as δ in units of parts per 
million (ppm) downfield from tetramethylsilane (δ 0.00), using the residual solvent 
signal as an internal standard: CDCl3 (1H NMR: δ 7.26, singlet; 13C NMR: δ 77.0, 
triplet). Multiplicities were given as: s (singlet), d (doublet), t (triplet), q (quartet), 
quintet, m (multiplets), dd (doublet of doublets), dt (doublet of triplets), and br 
(broad). Coupling constants (J) were recorded in Hertz (Hz). The number of proton 
atoms (n) for a given resonance was indicated by nH. The number of carbon atoms (n) 
for a given resonance was indicated by nC. High resolution Fast Atom Bombardment 
(FAB) and Electron Impact (EI) mass spectra were performed by Chemical and 
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Molecular Analysis Centre (CMAC) of the National University of Singapore. They 
were obtained on a Finnigan/MAT 95XL-T and Micromass VG7035 double focusing 
mass spectrometer of high resolution. High resolution Electrospray Ionization (ESI) 
mass spectra were obtained on a Shimadzu LCMS-IT-TOF spectrometer including an 
SPD-M20A prominence PDA detector, CBM-20A prominence communication bus 
module, CTO-20A prominence column oven, SIL-20AC prominence auto sampler, 
DGU-20A3 prominence degasser and LC-20AD prominence liquid chromatograph. 
Shimadzu Formula Predictor Software was used to process the data. MS and HRMS 
were reported in units of mass of charge ratio (m/z). Mass samples were dissolved in 
CH3CN (HPLC Grade) unless otherwise stated. Infrared spectra (IR) were recorded 
by dissolving samples in CHCl3 and spread as a thin film on NaCl cells unless 
otherwise stated. BIO-RAD Excalibur FTS3000 FTIR spectrometer was used to 
record the IR spectra. Optical rotations were recorded on a Jasco DIP-1000 
polarimeter with a sodium lamp of wavelength 589 nm and reported as follows; 
CT °
λα ][  (c = g/100 mL, solvent). Melting points were determined on a BÜCHI B-540 
melting point apparatus.  
Enantiomeric excesses were determined by chiral High Performance Liquid 
Chromatography (HPLC) analysis on Dionex HPLC UltiMate® 3000 series, including 
a variable wavelength UV/VIS detector VWD-3400 and LPG-3400A pump with 
manual injection valve. Data acquisitions were done using Chromeleon® software. 




5.1.3 Materials  
All commercial reagents were purchased from Sigma-Aldrich, Fluka, Alfa Aesar, 
Merck, TCI, and Acros of the highest purity grade. They were used without further 
purification unless specified. All solvents used, mainly hexane (Hex) and ethyl acetate 
(EtOAc), were distilled. Anhydrous DCM was freshly distilled from CaH2. Anhydrous 
THF was freshly distilled from Na/benzophenone. MeCN and CHCl3 were distilled 
from CaH2. Anhydrous hexane was purchased from Sigma-Aldrich. All compounds 
synthesized were stored in a −20 °C freezer and light-sensitive compounds were 
protected with aluminium foil. Catalyst 1b was synthesized previously by our group 
with some modifications.1 It was basified with 5M KOH aqueous solution instead of 
solid K2CO3 and subsequent re-crystallized from hexane. 
5.2 Preparation and Characterization of Substrates and Products  
5.2.1 Preparation and characterization of 3-alkynoates 
Representative procedure for synthesis of 3-alkynoates2 
 
A solution of phenylacetylene 119a (693 µL, 5.00 mmol, 1.00 equiv) and CuI 
(47.6 mg, 0.25 mmol, 0.050 equiv) was stirred in 5.00 mL of MeCN at room 
temperature under N2 atmosphere. Subsequently, tert-butyl 2-diazoacetate 120 (550 
µL, 5.00 mmol, 1.00 equiv) was added dropwise. The reaction was stirred overnight 
after which it was directly purified by flash chromatography to yield tert-butyl 
                                                        
1 Ye, W.; Leow, D.; Goh, S. L. M.; Tan, C.-T.; Chian, C.-H.; Tan, C.-H. Tetrahedron Lett. 2006, 47, 1007–1010. 
2 Suárez, A.; Fu, G. C. Angew. Chem. Int. Ed. 2004, 43, 3580–3582. 
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4-phenylbut-3-ynoate 121a with allenoate 122a (8%) as inseparable minor side 
product. The 3-allenoates were removed by Method A or B.  
Method A (3-alkynoates 121a–h, 121m): The 3-alkynoate and allenoate mixture 
(720 g, 3.33 mmol, 1.00 equiv) was dissolved in 3.3 mL of wet CHCl3. Pyridinium 
tribromide (PyHBr3) (106 mg, 0.333 mmol, 1.25 equiv to allenoate) was added to the 
solution mixture and stirred at room temperature for 16 h. It was then passed through 
a short of plug of silica gel. After removal of solvent, it was purified by flash 
chromatography to yield tert-butyl 4-phenylbut-3-ynoate 121a. If allenoate was still 
present, the procedure was repeated again.  
Method B (3-alkynoates 121i–l): A solution of the 3-alkynoate and allenoate 
mixture and large excess (~10 equiv.) of cyclopentadiene monomer were heated at 
80 °C for 10 h after which it was directly purified by flash chromatography to yield 
tert-butyl 5-hydroxypent-3-ynoate 121i. 
tert-Butyl 4-phenylbut-3-ynoate (121a) Pale yellow oil; 43% yield; 1H NMR (500 
MHz, CDCl3): δ 7.45–7.42 (m, 2H), 7.30–7.27 (m, 3H), 3.42 (s, 2H), 1.50 (s, 9H) ppm; 
13C NMR (125 MHz, CDCl3): δ 167.4, 131.7, 128.1, 128.0, 123.2, 83.3, 81.9, 81.8, 
28.0, 27.9 ppm; IR (film): 2980, 2251, 1740, 1491, 1369, 1279, 1261, 1149, 757, 692 
cm-1; HRMS (FAB) m/z: C14H16O2+ ([M+H]+), Calc. 216.1145, Found 216.1155; 





tert-Butyl 4-(4-tert-butylphenyl)but-3-ynoate (121b) Pale yellow oil; 50% yield; 1H 
NMR (500 MHz, CDCl3): 7.38–7.37 (m, 2H), 7.32–7.30 (m, 2H), 3.41 (s, 2H), 1.50 (s, 
9H), 1.30 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3): δ 167.5, 151.2, 131.4, 125.1, 
120.2, 123.2, 83.3, 81.8, 81.1, 34.7, 31.1, 28.0 ppm; IR (film): 3019, 2967, 2290, 
1735, 1370, 1216, 1151, 837, 756, 668 cm-1; HRMS (FAB) m/z: C18H24O2+ ([M+H]+), 
Calc. 272.1771, Found 272.1783; HPLC analysis: Chiralpak IC (Hex/IPA = 98.5/1.5, 
0.2 mL/min, 210 nm, 23 °C) 38.5 min. 
 
 
tert-Butyl 4-m-tolylbut-3-ynoate (121c) Pale yellow oil; 50% yield; 1H NMR (500 
MHz, CDCl3): 7.27 (s, 1H), 7.24 (d, J = 7.6 Hz, 1H), 7.17 (t, J = 7.6 Hz, 1H), 7.10 (d, 
J = 7.6 Hz, 1H), 3.41 (s, 2H), 2.31 (s, 3H), 1.50 (s, 9H) ppm; 13C NMR (125 MHz, 
CDCl3): δ 167.4, 137.8, 132.3, 128.9, 128.7, 128.0, 123.0, 83.5, 81.8, 81.4, 28.0, 27.9, 
21.1 ppm; IR (film): 2979, 2931, 2240, 1740, 1369, 1287, 1149, 785, 692 cm-1; 
HRMS (FAB) m/z: C15H19O2+ ([M+H]+), Calc. 231.1380, Found 231.1381; HPLC 
analysis: Chiralpak IC (Hex/IPA = 95/5, 0.5 mL/min, 210 nm, 23 °C) 11.0 min. 
  
 
tert-Butyl 4-(4-fluorophenyl)but-3-ynoate (121d) Pale yellow oil; 66% yield; 1H 
NMR (500 MHz, CDCl3): 7.42–7.39 (m, 2H), 7.00–6.96 (m, 2H), 3.40 (s, 2H), 1.49 (s, 
Chapter 5 
 92
9H) ppm; 13C NMR (125 MHz, CDCl3): δ 167.3, 162.35 (d, J = 249.3 Hz, 1C), 
133.56 (d, J = 8.3 Hz, 1C), 119.24 (d, J = 3.7 Hz, 1C), 115.40 (d, J = 22.0 Hz, 1C), 
82.3, 82.0, 81.6, 28.0, 27.8 ppm; 19F NMR (282 MHz, CDCl3): −35.39–−35.49 (m, 1F) 
ppm; IR (film): 2980, 2297,1741, 1509, 1222, 1150, 837 cm-1; HRMS (FAB) m/z: 
C14H15O2F1+ ([M+H]+), Calc. 234.1051, Found 234.1056; HPLC analysis: Chiralcel 
OJH (Hex/IPA = 98/2, 0.5 mL/min, 210 nm, 23 °C) 18.0 min. 
 
 
tert-Butyl 4-(6-methoxynaphthalen-2-yl)but-3-ynoate (121e) Pale yellow solid; mp: 
73.7–74.0 °C; 53% yield; 1H NMR (500 MHz, CDCl3): 7.90 (s, 1H), 7.68–7.63 (m, 
2H), 7.48–7.46 (m, 1H), 7.15–7.13 (m, 1H), 7.08 (s, 1H), 3.90 (s, 3H), 3.47 (s, 2H), 
1.52 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3): δ 167.4, 158.1, 134.0, 131.3, 129.2, 
129.1, 128.4, 126.6, 119.2, 118.1, 105.7, 83.8, 81.8, 81.4, 55.2, 27.9 ppm; IR (film): 
2975, 2286, 1743, 1602, 1484, 1247, 1148, 859 cm-1; HRMS (FAB) m/z: C19H20O3+ 
([M+H]+), Calc. 296.1407, Found 296.1406; HPLC analysis: Chiralpak IC (Hex/IPA = 
95/5, 0.5 mL/min, 254 nm, 23 °C) 19.1 min. 
 
 
tert-Butyl 4-(thiophen-3-yl)but-3-ynoate (121f) Yellow oil; 45% yield; 1H NMR 
(500 MHz, CDCl3): 7.42 (d, J = 2.5 Hz, 1H), 7.23–7.22 (m, 1H), 7.10 (d, J = 5.0 Hz, 
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1H), 3.39 (s, 2H), 1.49 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3): δ 167.3, 130.0, 
128.5, 125.0, 122.1, 81.9, 81.4, 78.5, 28.0 27.8 ppm; IR (film): 3019, 2400, 2253, 
1734, 1216, 1151, 909, 760, 669 cm-1; HRMS (FAB) m/z: C12H14O232S1+ ([M+H]+), 
Calc. 222.0709, Found 222.0714; HPLC analysis: Chiralpak IC (Hex/IPA = 98/2, 0.5 
mL/min, 210 nm, 23 °C) 14.8 min. 
 
 
tert-Butyl 4-(2-methoxyphenyl)but-3-ynoate (121g) Yellow oil; 63% yield; 1H 
NMR (500 MHz, CDCl3): 7.42–7.40 (m, 1H), 7.27–7.24 (m, 1H), 6.89–6.84 (m, 2H), 
3.87 (s, 3H), 3.47 (s, 2H), 1.49 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3): δ 167.4, 
160.0, 133.8, 129.4, 120.3, 112.3, 110.6, 85.9, 81.7, 79.5, 55.7, 28.2, 27.9 ppm; IR 
(film): 3020, 2254, 1736, 1494, 1216, 909, 768, 669 cm-1; HRMS (FAB) m/z: 
C15H18O3+ ([M+H]+), Calc. 246.1250, Found 246.1241. 
 
 
tert-Butyl 4-(2-bromophenyl)but-3-ynoate (121h) Pale yellow oil; 34% yield; 1H 
NMR (500 MHz, CDCl3): 7.55 (d, J = 8.2 Hz, 1H), 7.48–7.46 (m, 1H), 7.24–7.21 (m, 
1H), 7.15–7.12 (m, 1H), 3.47 (s, 2H), 1.50 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3): 
δ 167.0, 133.6, 132.3, 129.2 126.9, 125.4, 125.3, 86.8, 82.1, 81.9, 28.1 28.0 ppm; IR 
(film): 2980, 2203, 1737, 1642, 1470, 1369, 1150, 755 cm-1; HRMS (FAB) m/z: 
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C14H16O279Br1+ ([M+H]+), Calc. 295.0316, Found 295.0316, 61% rel., C14H16O281Br1+ 
([M+H]+), Calc. 297.0308, Found 297.0310, 55% rel.. 
 
 
tert-Butyl 5-hydroxypent-3-ynoate (121i) Colorless oil; 84% yield; 1H NMR (500 
MHz, CDCl3): δ 4.29 (t, J = 2.2 Hz, 2H), 3.24 (t, J = 2.2 Hz, 2H), 1.47 (s, 9H) ppm; 
13C NMR (125 MHz, CDCl3): δ 167.7, 82.1, 81.8, 77.6, 50.8, 27.8, 27.0 ppm; IR 
(film): 3154, 3000, 2254, 1734, 1469, 1381, 1230, 1196, 909, 736, 650 cm-1; LRMS 




tert-Butyl 5-hydroxy-5-methylhex-3-ynoate (121j) Colorless oil; 80% yield; 1H 
NMR (500 MHz, CDCl3): δ 3.20 (s, 2H), 1.52 (s, 6H), 1.47 (s, 9H) ppm; 13C NMR 
(125 MHz, CDCl3): δ 167.7, 88.3, 81.8, 74.3, 64.9, 31.3, 27.9, 27.0 ppm; IR (film): 
3155, 2994, 2254, 1794, 1735, 1469, 1382, 1236, 1194, 903, 747, 650 cm-1; LRMS 




tert-Butyl 5-(benzyloxy)-5-methylhex-3-ynoate (121k) Colorless oil; 74% yield; 1H 
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NMR (500 MHz, CDCl3): δ 7.38–7.31 (m, 4H), 7.25–7.24 (m, 1H), 4.64 (s, 2H), 3.23 
(s, 2H), 1.54 (s, 6H), 1.46 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3): δ 167.3, 139.2, 
128.2, 127.7, 127.2, 85.4, 81.7, 76.9, 70.7, 66.4, 28.9, 27.9, 27.2 ppm; IR (film): 3155, 
2989, 2253, 1794, 1735, 1469, 1382, 1239, 1194, 910, 746, 650 cm-1; LRMS (ESI) 
m/z: 310.9; HRMS (ESI) m/z: C18H24O3Na1+ ([M+Na]+), Calc. 311.1618, Found 
311.1625; Chiralpak IC (Hex/IPA = 98/2, 1.0 mL/min, 210 nm, 23°C) 4.9 min. 
 
 
tert-Butyl 5-(benzyloxycarbonylamino)pent-3-ynoate (121l) Colorless oil; 82% 
yield; 1H NMR (500 MHz, CDCl3): δ 7.37–7.31 (m, 5H), 5.11 (s, 2H), 4.93 (s, NH), 
4.02(s, 2H), 3.19(s, 2H), 1.46 (s, 9H) ppm; 13C NMR (75 MHz, CDCl3): δ 167.3, 
155.8, 136.2, 128.4, 128.1, 81.9, 79.0, 75.8, 66.9, 31.1, 27.9, 27.0 ppm; IR (film): 
3452, 3154, 3000, 2254, 1794, 1727, 1469, 1382, 1235, 1194, 910, 734, 651 cm-1; 




tert-Butyl 5-(phthalimido)pent-3-ynoate (121m) White solid; 80% yield; 1H NMR 
(500 MHz, CDCl3): δ 7.87 (q, J = 3.2 Hz, 2H), 7.73 (q, J = 3.2 Hz, 2H), 4.48 (t, J = 
2.2 Hz, 2H), 3.16 (t, J = 2.2 Hz, 2H), 1.43 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3): 
δ 167.0, 166.9, 134.1, 132.0, 123.4, 81.9, 76.6, 75.7, 27.8, 27.4, 27.1 ppm; IR (film): 
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3155, 3002, 2254, 1721, 1469, 1391, 1232, 1202, 911, 747, 650 cm-1; mp: 98.2 – 
99.4 °C; LRMS (FAB) m/z: 300.1; HRMS (FAB) m/z: C17H18O4N1+ ([M+H]+), Calc. 
300.1230, Found 300.1238; HPLC analysis: Chiralpak IB (Hex/IPA = 98/2, 1.0 
mL/min, 210 nm, 23°C) 28.3 min. 
 
5.2.2 Representative Procedure for Enantioselective Synthesis of Chiral 
Allenoates by Bicyclic Guanidine 1b Catalyzed Isomerization of 3-Alkynoates 
For the enantioselective synthesis of allenoates 122a-h: 
Ph










CO2tBu121a 122a  
Catalyst 1b (0.45 mg, 0.0020 mmol, 0.020 equiv.) was dissolved in hexane (16.0 
mL) in a 50 mL flame-dried test-tube capped with rubber septum and stirred at 
−20 °C for 10 min. 3-Alkynoate 121a (21.6 mg, 0.100 mmol, 1.00 equiv.) was then 
added dropwise under N2 atmosphere. After stirring for 30 h, the reaction was filtered 
through a short plug of silica gel to remove catalyst, which afforded an inseparable 
mixture of 3-alkynoate 121a and allenoate 122a as yellow liquid. The percentage of 
allenoate 122a was determined by 1H NMR analysis. The absolute configuration of 
the allenes was determined by the Lowe-Brewster rule.3  
(S)-tert-butyl 4-phenylbuta-2,3-dienoate (122a) Yellow oil; >99% yield (70% 
conversion); 1H NMR (500 MHz, CDCl3): δ 7.34–7.29 (m, 5H), 6.57 (d, J = 6.3 Hz, 
1H), 5.92 (d, J = 6.3 Hz, 1H), 1.49 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3): δ 
                                                        
3 (a) Lowe, G. Chem. Commun. 1965, 411–413. (b) Brewster, J. H. Top. Stereochem. 1967, 2, 1–72. 
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214.1, 164.3, 131.5, 128.8, 127.9, 127.4, 98.4, 93.4, 81.3, 28.0 ppm; IR (film): 2980, 
2253, 1951, 1713, 1369, 1276, 1148, 912, 734, 697 cm-1; 23][ Dα : +327.9 (c 1.5, 
CDCl3); HPLC analysis: Chiralpak IC (Hex/IPA = 98/2, 0.5 mL/min, 210 nm, 23 °C) 
11.5 (major), 15.3 min, 91% ee. 
 
 
4 mol% of catalyst 1b was used. 
(S)-tert-butyl 4-(4-tert-butylphenyl)buta-2,3-dienoate (122b) Yellow oil; >99% 
yield (68% conversion); 1H NMR (500 MHz, CDCl3): δ 7.36 (d, J = 8.8 Hz, 2H), 7.24 
(d, J = 8.8 Hz, 2H), 6.56 (d, J = 6.3 Hz, 1H), 5.90 (d, J = 6.3 Hz, 1H), 1.49 (s, 9H), 
1.31 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3): δ 214.2, 164.4, 151.1, 128.5, 127.1, 
125.7, 98.0, 93.2, 81.2, 34.6, 31.2, 28.1 ppm; IR (film): 2968, 2254, 1950, 1699, 1149, 
909, 732, 650 cm-1; 30][ Dα : +284.3 (c 1.9, CDCl3); HPLC analysis: Chiralpak IC 
(Hex/IPA = 98.5/1.5, 0.2 mL/min, 210 nm, 23 °C) 28.9 (major), 31.2 min, 94% ee. 
 
 
(S)-tert-butyl 4-m-tolylbuta-2,3-dienoate (122c) Yellow oil; >99% yield (62% 
conversion); 1H NMR (500 MHz, CDCl3): δ 7.23–7.20 (m, 1H), 7.11–7.06 (m, 3H), 
6.55 (d, J = 6.9 Hz, 1H), 5.91 (d, J = 6.3 Hz, 1H), 2.34 (s, 3H), 1.50 (s, 9H) ppm; 13C 
NMR (125 MHz, CDCl3): δ 214.1, 164.3, 138.4, 131.3, 128.7, 128.6, 128.0, 124.6, 
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98.4, 93.3, 81.2, 28.1, 21.3 ppm; IR (film): 2979, 1950, 1719, 1368, 1278, 1144, 783 
cm-1; 23][ Dα : +370.6 (c 1.5, CDCl3); HPLC analysis: Chiralpak IC (Hex/IPA = 95/5, 
0.5 mL/min, 210 nm, 23 °C) 9.5 (major), 11.3 min, 95% ee. 
 
 
(S)-tert-butyl 4-(4-fluorophenyl)buta-2,3-dienoate (122d) Yellow oil; >99% yield 
(70% conversion); 1H NMR (500 MHz, CDCl3): δ 7.27–7.24 (m, 2H), 7.03–6.99 (m, 
2H), 6.54 (d, J = 6.3 Hz, 1H), 5.91 (d, J = 6.3 Hz, 1H), 1.48 (s, 9H) ppm; 13C NMR 
(125 MHz, CDCl3): δ 213.9, 164.2, 162.44 (d, J = 247.4 Hz, 1C), 128.94 (d, J = 8.3 
Hz, 1C), 127.45 (d, J = 3.7 Hz, 1C), 115.82 (d, J = 22.0 Hz, 1C), 97.5, 93.6, 81.4, 
28.1 ppm; 19F NMR (282 MHz, CDCl3): −37.63–−37.73 (m, 1F) ppm; IR (film): 2981, 
2254, 1951, 1708, 1509, 1369, 1232, 1148, 910, 734 cm-1; 23][ Dα : +268.7 (c 1.6, 
CDCl3); HPLC analysis: Chiralcel OJH (Hex/IPA = 98/2, 0.5 mL/min, 210 nm, 23 °C) 






4 mol% of catalyst 1b was used. THF was used as the solvent. 
(S)-tert-butyl 4-(6-methoxynaphthalen-2-yl)buta-2,3-dienoate (122e) Pale yellow 
solid; >99% yield (80% conversion); 1H NMR (500 MHz, CDCl3): δ 7.68 (d, J = 8.2 
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Hz, 1H), 7.63 (s, 1H), 7.42–7.40 (m, 1H), 7.15–7.13 (m, 1H), 7.10 (d, J = 1.9 Hz, 1H), 
6.72 (d, J = 6.3 Hz, 1H), 5.99 (d, J = 6.3 Hz, 1H), 3.90 (s, 3H), 1.51 (s, 9H) ppm; 13C 
NMR (125 MHz, CDCl3): δ 214.5, 164.4, 157.9, 134.2, 129.3, 128.9, 127.3, 126.5, 
126.4, 125.4, 119.1, 105.9, 98.7, 93.5, 81.2, 55.2, 28.1 ppm; IR (film): 2982, 2254, 
1948, 1699, 1370, 1268, 1148, 909, 734 cm-1; 23][ Dα : +374.2 (c 2.4, CDCl3); HPLC 
analysis: Chiralpak IC (Hex/IPA = 95/5, 0.5 mL/min, 254 nm, 23 °C) 17.5 (major), 
23.3 min, 93% ee. 
 
 
4 mol% of catalyst 1b was used. 
(S)-tert-butyl 4-(thiophen-3-yl)buta-2,3-dienoate (122f) Yellow oil; >99% yield 
(39% conversion); 1H NMR (500 MHz, CDCl3): δ 7.29–7.27 (m, 1H), 7.17 (d, J = 3.2 
Hz, 1H), 7.05–7.04 (m, 1H), 6.64 (d, J = 6.3 Hz, 1H), 5.86 (d, J = 6.3 Hz, 1H), 1.48 (s, 
9H) ppm; 13C NMR (125 MHz, CDCl3): δ 214.7, 164.2, 126.4, 126.3, 125.0, 122.7, 
92.9, 92.7, 81.2, 28.0 ppm; IR (film): 2978, 2299, 1951, 1721, 1368, 1281, 1147, 781 
cm-1; 31][ Dα : +486.0 (c 0.9, CDCl3); HPLC analysis: Chiralpak IC (Hex/IPA = 98/2, 
0.5 mL/min, 210 nm, 23 °C) 13.1 (major), 17.3 min, 89% ee. 
 
 
THF was used as the solvent. 
(S)-tert-butyl 4-(2-methoxyphenyl)buta-2,3-dienoate (122g) Yellow oil; 98% yield 
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(60% yield); 1H NMR (500 MHz, CDCl3): δ 7.33–7.32 (m, 1H), 7.25–7.22 (m, 1H), 
6.95–6.91 (m, 2H), 6.88 (d, J = 8.2 Hz, 1H), 5.88 (d, J = 6.3 Hz, 1H), 3.84 (s, 3H), 
1.49 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3): δ 214.9, 164.7, 156.3, 129.1, 128.6, 
120.9, 120.1, 111.0, 92.7, 92.5, 81.0, 55.6, 28.1 ppm; IR (film): 2978, 1949, 1716, 
1494, 1250, 1144, 752 cm-1; HRMS (FAB) m/z: C15H18O3+ ([M+H]+), Calc. 246.1250, 
Found 246.1256; 26][ Dα : +302.5 (c 1.4, CDCl3); HPLC analysis: Chiralpak IC 
(Hex/IPA = 95/5, 0.5 mL/min, 210 nm, 23 °C) 13.0 (major), 16.0 min, 93% ee. 
 
 
(S)-tert-butyl 4-(2-bromophenyl)buta-2,3-dienoate (122h) Yellow oil; 99% yield 
(76% yield); 1H NMR (500 MHz, CDCl3): δ 7.56–7.55 (m, 1H), 7.44–7.42 (m, 1H), 
7.28–7.25 (m, 1H), 7.12–7.09 (m, 1H), 7.04 (d, J = 6.9 Hz, 1H), 5.95 (d, J = 6.3 Hz, 
1H), 1.50 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3): δ 214.7, 164.1, 133.1, 131.5, 
129.2, 129.1, 127.6, 122.8, 97.6, 93.6, 81.5, 28.1 ppm; IR (film): 2981, 2253, 1952, 
1707, 1302, 1150, 909, 734 cm-1; HRMS (EI) m/z: C14H15O279Br1+ ([M+H]+), Calc. 
294.0255, Found 294.0247, 100% rel., C14H15O281Br1+ ([M+H]+), Calc. 296.0235, 
Found 296.0234, 96% rel.; 24][ Dα : +194.9 (c 2.1, CDCl3); HPLC analysis: Chiralpak 
IC (Hex/IPA = 98/2, 0.5 mL/min, 210 nm, 23 °C) 12.2 (major), 16.7 min, 79% ee. 
 
For the enantioselective synthesis of allenoates 122i-m: 
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121i 122i  
Catalyst 1b (0.45 mg, 0.0020 mmol, 0.020 equiv.) in THF (30.0 mL) were stirred 
in a 50 mL r.b.f. at −20 °C. tert-butyl 5-hydroxypent-3-ynoate 121i (17.0 mg, 0.10 
mmol, 1.0 equiv.) was added as liquid after 30 min and stirred at −20 °C. After 
another 30 h, the reaction was completed. It was filtered through a short plug of silica 
gel to remove catalyst, which afforded a mixture of substrate 121i and product 122i as 
colourless oil. The percentage of 122i was shown by 1H NMR analysis. The absolute 
configuration of the allenes was determined by the Lowe-Brewster rule.3  
(S)-tert-butyl 5-hydroxypenta-2,3-dienoate (122i) Colorless oil; 98% yield (57% 
conversion); 1H NMR (500 MHz, CDCl3): δ 5.79 (q, J = 6.3 Hz, 1H), 5.65-5.63 (m, 
1H), 4.24 (dd, J = 2.5, 6.3 Hz, 2H), 2.51 (s, OH), 1.47(s, 9H) ppm; 13C NMR (125 
MHz, CDCl3): δ 211.2, 165.3, 96.3, 91.6, 81.5, 59.3, 28.0 ppm; IR (film): 3439, 3020, 
2400, 2361, 1963, 1696, 1290, 1216, 755, 669 cm-1; 24][ Dα : +47.1 (c 1.0, CHCl3); 
HPLC analysis: Chiralpak IC (Hex/IPA = 90/10, 1.0 mL/min, 210 nm, 23°C) 17.0 
(major), 18.1 min, 86% ee. 
 
 
4 mol% of catalyst 1b was used. 
(S)-tert-butyl 5-hydroxy-5-methylhexa-2,3-dienoate (122j) Colorless oil; 94% yield 
(59% conversion); 1H NMR (500 MHz, CDCl3): δ5.77 (d, J = 6.3 Hz, 1H), 5.62 (d, J 
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= 6.3 Hz, 1H), 1.46 (s, 9H), 1.40 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3): δ 209.6, 
165.1, 105.0, 92.4, 81.1, 69.9, 29.8, 29.1, 28.0 ppm; IR (film): 3404, 3017, 2933, 
2400, 1961, 1694, 1369, 1149, 753, 668 cm-1; 25][ Dα : +92.3 (c 0.9, CHCl3); HPLC 
analysis: Chiralpak IC (Hex/IPA = 90/10, 1.0 mL/min, 210 nm, 23°C) 5.3 (major), 6.1 
min, 94% ee. 
 
 
(S)-tert-butyl 5-(benzyloxy)-5-methylhexa-2,3-dienoate (122k) Colorless oil; 98% 
yield (79% conversion); 1H NMR (500 MHz, CDCl3): δ 7.38-7.31 (m, 5H), 5.63 (dd, J 
= 6.3, 8.2 Hz, 2H), 4.52 (dd, J = 11.4, 36.6 Hz, 2H), 1.46 (s, 9H), 1.44 (d, J = 1.3 Hz, 
6H) ppm; 13C NMR (125 MHz, CDCl3): δ 210.7, 164.9, 139.1, 128.3, 127.5, 127.3, 
101.5, 91.7, 81.0, 75.0, 65.5, 28.1, 27.5, 26.5 ppm; IR (film): 3155, 3041, 2988, 2254, 
1961, 1794, 1700, 1469, 1382, 1202, 909, 741, 650 cm-1;  25][ Dα : +54.1 (c 2.3, 
CHCl3); HPLC analysis: Chiralpak IC (Hex/IPA = 98/2, 1.0 mL/min, 210 nm, 23°C) 
5.5 (major), 16.3 min, 95% ee. 
 
 
4 mol% of catalyst 1b was used. 
(S)-tert-butyl 5-(benzyloxycarbonylamino)penta-2,3-dienoate (122l) Colorless oil; 
99% yield (65% conversion); 1H NMR (500 MHz, CDCl3): δ 7.36-7.30 (m, 5H), 
5.67-5.60 (m, 2H), 5.13-5.07 (m, 2H+NH), 3.90 (s, 2H), 1.46 (s, 3H) ppm; 13C NMR 
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(125 MHz, CDCl3): δ 211.2, 164.6, 156.1, 136.3, 128.4, 128.1, 128.0, 93.4, 92.1, 81.2, 
66.8, 38.5, 28.0 ppm; IR (film): 3449, 3019, 2892, 2400, 1965, 1713, 1513, 1215, 775, 
669 cm-1; 26][ Dα : +59.7 (c 1.8, CHCl3); HPLC analysis: Chiralpak IC (Hex/IPA = 95/5, 
1.0 mL/min, 210 nm, 23°C) 34.1 (major), 37.7 min, 91% ee. 
 
 
4 mol% of catalyst 1b was used. 
(S)-tert-butyl 5-(phthalimido)penta-2,3-dienoate (122m) White solid; 99% yield 
(94% conversion); 1H NMR (500 MHz, CDCl3): δ 7.85 (q, J = 3.2 Hz, 2H), 7.72 (q, J 
= 3.2 Hz, 2H), 5.70 (q, J = 6.3 Hz, 1H), 5.57 (quintet, J = 2.5 Hz, 1H), 4.43-4.36 (m, 
2H), 1.40 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3): δ 211.7, 167.3, 164.1, 134.0, 
131.9, 123.3, 92.5, 90.9, 81.1, 35.1, 27.8 ppm; IR (film): 3428, 3154, 3000, 2254, 
1967, 1718, 1470, 1388, 1239, 910, 744, 650 cm-1; mp: 92.3 – 93.3 °C; LRMS (FAB) 
m/z: 300.1; HRMS (FAB) m/z: C17H18O4N1+ ([M+H]+), Calc. 300.1230, Found 
300.1232; 27][ Dα : +120.5 (c 3.0, CHCl3); HPLC analysis: Chiralpak IB (Hex/IPA = 
98/2, 1.0 mL/min, 210 nm, 23°C) 15.1 (major), 16.4 min, 94% ee. 
 




Allenoate 122g (7.8 mg, 0.0316 mmol, 1.00 equiv, 93% ee) was dissolved in 0.30 
mL of dry CHCl3 in a 4 mL vial and stirred at 0 °C for 10 mins under an atmosphere 
of N2. N-Iodo succinimide (NIS) (7.8 mg, 0.347 mmol, 1.10 equiv) was added as a 
single portion in dark. The temperature was raised slowly to room temperature over 1 
h in dark. Then it was passed through a short plug of silica gel and washed with plenty 
of Hex/EtOAc = 4/1. The crude reaction mixture was subjected to flash 
chromatography using Hex/EtOAc = 12/1 to yield lactone 145a. Absolute 
configuration was assigned in analogous to lactone 145d.4  
(S)-4-iodo-5-(2-methoxyphenyl)furan-2(5H)-one (145a) Yellow solid; 49% yield; 
1H NMR (500 MHz, CDCl3): δ 7.41–7.37 (m, 1H), 7.08–7.06 (m, 1H), 6.99–6.95 (m, 
2H), 6.64 (d, J = 1.9 Hz, 1H), 6.34 (d, J = 1.3 Hz, 1H), 3.86 (s, 3H) ppm; 13C NMR 
(125 MHz, CDCl3): δ 171.5, 157.9, 131.2, 129.8, 128.2, 125.2, 121.00, 120.95, 111.4, 
85.2, 55.6 ppm; IR (film): 3155, 2254, 1757, 1254, 1157, 910, 736 cm-1; HRMS (ESI) 
m/z: C11H10O3I1+ ([M+H]+), Calc. 316.9675, Found 316.9674; HPLC analysis: 




A mixture of 3-alkynoate 121b and allenoate 122b (7.8 mg, 0.0286 mmol, 1.00 
                                                        
4 Shingu, K.; Hagishita, S.; Nakagawa, M. Tetrahedron Lett. 1967, 8, 4371–4374. 
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equiv, 94.0% ee, 68% conv) was dissolved in 0.30 mL of undistilled CHCl3 in a 4 mL 
vial. Pyridinium tribromide (PyHBr3) (6.8 mg, 0.214 mmol, 1.10 equiv to allenoate) 
was added as a single portion. The reaction was stirred for 1 h. Then it was passed 
through a short plug of silica gel and washed with plenty of Hex/EtOAc = 4/1. The 
crude reaction mixture was subjected to flash chromatography using Hex/EtOAc = 
12/1 to yield lactone 145c with 94% recovery of 3-alkynoate 121b. Absolute 
configuration was assigned in analogous to lactone 145d.4 
(S)-4-bromo-5-(4-tert-butylphenyl)furan-2(5H)-one (145c) Pale yellow solid; 60% 
yield; 1H NMR (500 MHz, CDCl3): δ 7.44 (d, J = 8.2 Hz, 2H), 7.21 (d, J = 8.2 Hz, 
2H), 6.43 (d, J = 1.9 Hz, 1H), 5.84 (s, 1H), 1.32 (s, 9H) ppm; 13C NMR (125 MHz, 
CDCl3): δ 170.4, 153.3, 129.4, 127.0, 126.0, 121.8, 87.1, 34.8, 31.2 ppm; IR (film): 
2968, 2254, 1763, 1642, 1151, 910, 739 cm-1; HRMS (ESI) m/z: C14H16O279Br1+ 
([M+H]+), Calc. 295.0334, Found 295.0332, 100% rel., C14H16O281Br1+ ([M+H]+), 
Calc. 297.0314, Found 297.0321, 96% rel.; HPLC analysis: Chiralpak IC (Hex/IPA = 
95/5, 1.0 mL/min, 210 nm, 23 °C) 21.9, 25.8 (major) min, 86% ee. 
 
122m, 93% ee, 97% conv. 146a, 86% ee
Au(PPh3)Cl (10 mol%)
AgOTf (10 mol%)
CH2Cl2, rt, 1 d














Au(PPh3)Cl (1.5 mg, 0.0030 mmol, 0.10 equiv) and AgOTf (0.8 mg, 0.0030 mmol, 
0.10 equiv) were weighed into a 4 mL vial under N2 atmosphere. A solution of 
allenoate 122m (9.0 mg, 0.0300 mmol, 1.00 equiv, 93.0% ee, 97% conv) in 0.30 mL 
of dry CH2Cl2 was added to the vial containing the catalysts. The reaction was stirred 
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for 1 d. Then it was passed through a short plug of silica gel and washed with plenty 
of hex/EtOAc = 2/1. The crude reaction mixture was subjected to flash 
chromatography using hex/EtOAc = 1/1 to yield lactone 146a with 3% of organogold 
complex 146b as an inseparable mixture. Absolute configuration was assigned in 
analogous to lactone 145d. 
The structure of lactone 146a was individually confirmed by subjecting the 
mixture of 146a and 146b to hydrolysis with 2.00 equiv. of p-toluenesulfonic acid 
monohydrate in toluene at 65 °C for half an hour.5 Then it was passed through a short 
plug of silica gel and washed with plenty of hex/EtOAc = 2/1. The crude reaction 
mixture was subjected to flash chromatography using hex/EtOAc = 1/1 to yield pure 
lactone 146a. 
(R)-5-(phthalimidomethyl)furan-2(5H)-one (146a) White solid; 77% yield; mp: 
177–179 (dec.) °C; 1H NMR (500 MHz, CDCl3): δ 7.86–7.83 (m, 2H), 7.75–7.72 (m, 
2H), 7.53 (dd, J = 5.7, 1.3 Hz, 1H), 6.13 (dd, J = 5.7, 1.9 Hz, 1H), 5.36–5.33 (m, 1H), 
4.08 (dd, J = 14.2, 5.4 Hz, 1H), 4.01 (dd, J = 14.5, 5.7 Hz, 1H) ppm; 13C NMR (125 
MHz, CDCl3): δ 171.9, 167.7, 153.4, 134.4, 131.6, 123.6, 122.7, 80.3, 39.1 ppm; IR 
(film): 3092, 3020, 2401, 1769, 1715, 1395, 1216, 756 cm-1; HRMS (ESI) m/z: 
C13H9NO4+ ([M+H]+), Calc. 244.0610, Found 244.0616; HPLC analysis: Chiralpak IA 
(Hex/IPA = 70/30, 1.0 mL/min, 210 nm, 23 °C) 12.6 (major), 14.4 min, 86% ee. 
 
(S)-[2-(phthalimidomethyl)-5-oxo-2,5-dihydrofuran-3-yl]triphenylphosphinegold
                                                        
5 Liu, L.-P.; Xu, B.; Mashuta, M. S.; Hammond, G. B. J. Am. Chem. Soc. 2008, 130, 17642–17643. 
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(I) (146b) White foamy solid; 3% yield; 1H NMR (500 MHz, CDCl3): δ 7.64 (dd, J = 
5.7, 3.2 Hz, 2H), 7.55 (dd, J = 5.7, 3.2 Hz, 2H), 7.52–7.40 (m, 15H), 6.01 (dd, J = 3.8, 
1.9 Hz, 1H), 5.54 (dt, J = 6.9, 1.9 Hz, 1H), 4.07 (dd, J = 13.9, 6.3 Hz, 1H), 3.97 (dd, J 
= 13.9, 8.2 Hz, 1H) ppm; 13C NMR (125 MHz, CDCl3): δ 204.4, 203.5, 167.8, 134.2, 
134.1, 133.8, 131.9, 131.5, 129.3, 129.2, 123.1, 89.0, 88.9, 41.2 ppm; 31P NMR (202 
MHz, CDCl3): 43.5 (s, 1P) ppm; HRMS (ESI) m/z: C31H24NO4PAu+ ([M+H]+), Calc. 
702.1108, Found 702.1106; HPLC analysis: Chiralpak IA (Hex/IPA = 70/30, 1.0 
mL/min, 210 nm, 23 °C) 10.3 (major), 18.4, 84% ee. 
 
5.2.4 Procedures for cycloadditions of axially chiral allenoates 
 
A mixture of (S)-tert-butyl 5-hydroxypenta-2, 3-dienoate 122i and tert-butyl 
5-hydroxypent-3-ynoate 121i (14.8 mg, 0.050 mmol, 122i : 121i = 57 : 43, ee of 122i: 
86%) was dissolved in toluene (0.5mL), the fresh distilled cyclopenadiene (30uL) was 
added in one portion. This mixture was heated at 80°C for 12 h, after the reaction was 
completed, the solvent was removed in vacuo. The crude product was purified by 
gradient elution (Hex/EtOAc = 20/1 to 8/1) to afford a mixture of exo (149a) and 
endo (148a) products as colorless oil. At the meaning time, 121i was recovered as 
colorless oil. 
(1S,2S,4R,Z)-tert-butyl 




3-(2-hydroxyethylidene)bicyclo[2.2.1]hept-5-ene-2-carboxylate (endo, 148a) 
Colorless oil; 85% yield (148a : 149a = 4: 1); recover of 121i: 70% yield; 1H NMR 
(500 MHz, CDCl3): δ 6.24 (dd, J = 3.2, 5.1 Hz, 1H, endo), 6.18-6.16 (m, 1H, exo), 
6.04 (dd, J = 3.2, 5.7 Hz, 1H, endo), 5.83-5.77 (m, 1H, endo), 5.83-5.77 (m, 1H, exo), 
4.00-3.89 (m, 2H, endo), 4.00-3.89 (m, 2H, exo), 3.50-3.48 (m, 1H, endo), 3.30-3.29 
(m, 1H, endo), 3.23-3.22 (m, 1H, endo), 3.23-3.22 (m, 1H, exo), 3.17 (s, 1H, exo), 
2.91 (s, 1H, exo), 1.78 (d, J = 8.9 Hz, 1H, exo), 1.63 (dt, J = 1.9, 6.7 Hz, 1H, endo), 
1.57-1.55 (m, 1H, exo), 1.47 (s, 9H, exo), 1.46 (d, J = 3.2 Hz, 1H, endo), 1.43 (s, 9H, 
endo) ppm; 13C NMR (75 MHz, CDCl3): δ 172.8, 143.9, 143.2, 137.4, 136.3, 136.1, 
133.7, 121.4, 121.3, 81.1, 80.9, 52.0, 50.5, 49.9, 48.8, 48.6, 47.6, 47.0, 46.6, 28.0 ppm; 
IR (film): 3431, 3019, 2886, 2400, 1716, 1521, 1215, 759, 669 cm-1; LRMS (ESI) m/z: 
259.0; HRMS (ESI) m/z: C14H20O3Na1+ ([M+Na]+), Calc. 259.1305, Found 259.1304; 
HPLC analysis: Chiralpak IC (Hex/IPA = 95/5, 1.0 mL/min, 210 nm, 23°C) 12.7 (exo, 









(148b) White solid (148b), Colorless oil (149b); 98% yield (148b : 149b = 3: 1); 
recover of 121l: 60% yield;  
149b: 1H NMR (500 MHz, CDCl3): δ 7.35-7.29 (m, 5H), 6.16-6.14 (m, 2H), 5.57-5.55 
(m, 1H), 5.09 (s, 2H), 4.94 (s, NH), 3.87-3.82 (m, 1H), 3.58-3.51 (m, 1H), 3.19 (s, 1H), 
3.13 (s, 1H), 2.84 (s, 1H), 1.85 (d, J = 8.2 Hz, 1H), 1.54 (d, J = 8.9 Hz, 1H), 1.45 (s, 
9H) ppm; 13C NMR (125 MHz, CDCl3): δ 172.8, 156.3, 144.1, 137.4, 136.7, 136.3, 
128.4, 128.0, 127.9, 118.3, 80.9, 66.5, 50.4, 48.6, 47.7, 46.9, 40.9, 28.0 ppm; IR (film): 
3443, 3020, 2891, 2400, 1713, 1516, 1216, 760, 669 cm-1; LRMS (ESI) m/z: 392.0; 
HRMS (ESI) m/z: C22H27O4N1Na1+ ([M+Na]+), Calc. 392.1832, Found 392.1841; 
25][ Dα : +90.6 (c 0.5, CHCl3); HPLC analysis: Chiralpak IC (Hex/IPA = 90/10, 1.0 
mL/min, 210 nm, 23°C) 11.4 (major), 12.8 min, 85% ee; 
 
 
148b: 1H NMR (500 MHz, CDCl3): δ 7.35-7.29 (m, 5H), 6.22-6.20 (m, 1H), 6.03 (dd, 
1H, J = 2.6, 5.1 Hz), 5.57 (s, 1H), 5.16 (s, NH), 5.09 (s, 2H), 3.92-3.88 (m, 1H), 
3.45-3.42 (m, 2H), 3.27 (s, 1H), 3.21 (s, 1H), 1.61 (d, J = 8.2 Hz, 1H), 1.45 (d, J = 5 
Hz, 1H), 1.42 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3): δ 171.9, 156.3, 142.8, 136.8, 
135.8, 133.6, 128.4, 128.0, 127.9, 118.3, 80.5, 66.4, 52.0, 49.9, 48.5, 46.6, 41.2, 27.9 
ppm; IR (film): 3437, 3017, 2889, 2399, 1716, 1511, 1208, 770, 668 cm-1; mp: 92.3 – 
93.3 °C; LRMS (ESI) m/z: 392.0; HRMS (ESI) m/z: C22H27O4N1Na1+ ([M+Na]+), 
Calc. 392.1832, Found 392.1825; 26][ Dα : −111.2 (c 1.4, CHCl3); HPLC analysis: 
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3-(2-(phthalimido)ethylidene)bicyclo[2.2.1]hept-5-ene-2-carboxylate (exo, 149c) 
and (1R,2S,4S,Z)-tert-butyl 
3-(2-(phthalimido)ethylidene)bicyclo[2.2.1]hept-5-ene-2-carboxylate (endo, 148c) 
Colorless oil; 99% yield (148c : 149c = 2: 1); 1H NMR (500 MHz, CDCl3): δ 
7.83-7.80 (m, 2H, exo), 7.83-7.80 (m, 2H, endo), 7.69-7.67 (m, 2H, exo), 7.69-7.67 (m, 
2H, endo), 6.20 (dd, J = 3.2, 5.7 Hz, 1H, endo), 6.18 (dd, J = 2.6, 5.1 Hz, 1H, exo), 
6.10 (dd, J = 3.2, 5.7 Hz, 1H, endo), 6.10 (dd, J = 3.2, 5.7 Hz, 1H, exo), 5.55-5.53 (m, 
1H, endo), 5.55-5.53 (m, 1H, exo), 4.34-4.30 (m, 1H, endo), 4.27 (dd, J = 5.1, 15.6 Hz, 
1H, exo), 4.21 (dd, J = 9.5, 15.2 Hz, 1H, exo), 4.12 (dd, J = 10.1, 15.2 Hz, 1H, endo), 
3.73 (s, 1H, endo), 3.32 (s, 1H, endo), 3.19-3.15 (m, 1H, endo), 3.19-3.15 (m, 2H, 
exo), 3.11 (s, 1H, exo), 1.92 (d, J = 8.2 Hz, 1H, exo), 1.59-1.58 (m, 1H, endo), 
1.54-1.52 (m, 1H, exo), 1.50 (s, 9H, exo), 1.45 (s, 9H, endo), 1.42 (d, J = 8.2 Hz, 1H, 
endo) ppm; 13C NMR (125 MHz, CDCl3): δ 172.4, 171.5, 168.0, 167.9, 144.8, 143.9, 
137.4, 136.3, 135.3, 134.5, 133.8, 132.4, 132.3, 123.1, 123.0, 116.1, 115.9, 80.8, 80.4, 
52.2, 50.3, 49.9, 49.2, 48.9, 47.7, 47.2, 46.5, 38.2, 37.6, 28.1, 28.0 ppm; IR (film): 
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3429, 3004, 2823, 2254, 1712, 1237, 1196, 909, 734, 650 cm-1; LRMS (ESI) m/z: 
388.0; HRMS (ESI) m/z: C22H23O4N1Na1+ ([M+Na]+), Calc. 388.1519, Found 
388.1527; HPLC analysis: Chiralpak IC (Hex/IPA = 90/10, 1.0 mL/min, 210 nm, 
23°C) 8.2 (exo, major), 10.0 (endo, major), 12.6(exo), 16.5 (endo) min, 93 (exo) : 93 
(endo) % ee. 
 
5.2.5 Representative procedure for Brønsted-base catalyzed tandem 
isomerization-Michael reactions of alkynes 
 
To a clear and dry vial, tert-butyl 6-hydroxyoct-3-ynoate 140a (21.2mg, 0.1mmol), 
a stirring bar and anhydrous CH2Cl2 (0.9 mL) were added in this sequence. After 
stirring at room temperature for a while, 1,5,7-triazabicyclo[4.4.0]dec-1-ene (TBD) 
(1.4mg, 0.01 mmol) in anhydrous CH2Cl2 (0.1 mL) were added to the mixture in one 
portion. After the reaction completed in 1 hour, the reaction mixture was concentrated 
and loaded onto a short silica gel column, followed by flash chromatography. Product 
165a (20.0mg) was obtained as colorless oil in 94% yield. 
(E)-tert-butyl 2-(5-ethyldihydrofuran-2(3H)-ylidene)acetate (165a) Colorless oil; 
94% yield; 1H NMR (300 MHz, CDCl3): δ 5.28 (s, 1H), 4.32-4.23 (m, 1H), 3.29-3.18 
(m, 1H), 2.97-2.84 (m, 1H), 2.20-2.10 (m, 1H), 1.71-1.61 (m, 3H), 1.45 (s, 9H), 0.95 (t, 
J = 7.3 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 175.5, 168.3, 90.9, 84.9, 78.7, 
30.0, 28.8, 28.4, 27.9, 9.7 ppm; IR (film): 2976, 2937, 1688, 1636, 1368, 1114, 759 
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cm-1; LRMS (ESI) m/z: 234.9; HRMS (ESI) m/z: C12H20O323Na1+ ([M+Na]+), Calc. 
235.1305, Found 235.1305. 
 
 
(E)-tert-butyl 2-(5-methyldihydrofuran-2(3H)-ylidene)acetate (165b) Colorless oil; 
92% yield; 1H NMR (300 MHz, CDCl3): δ 5.18 (s, 1H), 4.51-4.44 (m, 1H), 3.31-3.21 
(m, 1H), 2.98-2.85 (m, 1H), 2.22-2.13 (m, 1H), 1.69-1.60 (m, 3H), 1.45 (s, 9H), 1.33 (t, 
J = 7.3 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 175.3, 168.3, 91.0, 79.8, 78.8, 
31.1, 30.5, 28.4, 20.4 ppm; IR (film): 3023, 2980, 1690, 1637, 1368, 1216, 1114, 751 
cm-1; LRMS (ESI) m/z: 220.9; HRMS (ESI) m/z: C11H28O323Na1+ ([M+Na]+), Calc. 
221.1148, Found 221.1153. 
 
 
(E)-tert-butyl 2-(dihydrofuran-2(3H)-ylidene)acetate (2c) 6  Colorless oil; 82% 
yield; 1H NMR (300 MHz, CDCl3): δ 5.23 (s, 1H), 4.18 (t, J = 7.3 Hz, 1H), 3.05 (dt, J 
= 1.8, 7.9 Hz, 2H), 2.11-2.01 (m, 2H), 1.45 (s, 9H) ppm; 13C NMR (75 MHz, CDCl3): 
δ 175.5, 168.1, 91.4, 78.9, 71.3, 30.0, 28.4, 20.0 ppm; IR (film): 3028, 2982, 1716, 
1641, 1369, 1155, 1114, 744 cm-1; LRMS (EI) m/z: 185.1; HRMS (EI) m/z: C10H17O3+ 
([M+1]+), Calc. 185.1178, Found 185.1172. 
 
                                                        




(E)-tert-butyl 2-(5-(4-bromophenyl)dihydrofuran-2(3H)-ylidene)acetate (165d) 
Colorless oil; 92% yield; 1H NMR (300 MHz, CDCl3): δ 7.48 (d, J = 8.5 Hz, 2H), 
7.17 (d, J = 8.5 Hz, 2H), 5.35 (s, 1H), 5.30 (t, J = 7.3 Hz, 1H), 3.37-3.27 (m, 1H), 
3.10-2.98 (m, 1H), 2.55-2.44 (m, 1H), 2.02-1.89 (m, 1H), 1.48 (s, 9H) ppm; 13C NMR 
(75 MHz, CDCl3): δ 174.6, 167.9, 139.2, 131.7, 127.2, 122.0, 92.1, 83.3, 79.1, 32.5, 
30.1, 28.4 ppm; IR (film): 3019, 2980, 1692, 1643, 1368, 1216, 1111, 779 cm-1; 
LRMS (EI) m/z: 338.0; 340.0; HRMS (EI) m/z: C16H19O379Br1+ ([M]+), Calc. 





(E)-ethyl 2-(5-phenyldihydrofuran-2(3H)-ylidene)acetate (165e) Colorless oil; 
89% yield; 1H NMR (300 MHz, CDCl3): δ 7.40-7.29 (m, 5H), 5.43 (s, 1H), 5.39 (t, J 
= 7.3 Hz, 1H), 4.15 (q, J = 7.0 Hz, 2H), 3.45-3.35 (m, 1H), 3.15-3.02 (m, 1H), 
2.57-2.47 (m, 1H), 2.10-1.97 (m, 1H), 1.28 (t, J = 7.3 Hz, 3H) ppm; 13C NMR (75 
MHz, CDCl3): δ 176.0, 168.6, 139.9, 128.6, 128.2, 125.6, 90.0, 84.5, 59.3, 32.4, 30.5, 
14.5 ppm; IR (film): 3019, 2900, 1696, 1643, 1374, 1216, 1116, 778 cm-1; LRMS (EI) 





(E)-ethyl 2-(5-(furan-2-yl)dihydrofuran-2(3H)-ylidene)acetate (165f) Colorless oil; 
89% yield; 1H NMR (300 MHz, CDCl3): δ 7.42 (s, 1H), 6.38-6.34 (m, 2H), 5.38 (t, J 
= 7.0 Hz, 1H), 5.33 (s, 1H), 4.13 (q, J = 7.0 Hz, 2H), 3.48-3.38 (m, 1H), 3.19-3.07 (m, 
1H), 2.41-2.30 (m, 2H), 1.28 (t, J = 7.0 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 
175.3, 168.5, 151.5, 143.2, 110.4, 108.8, 90.2, 77.6, 59.3, 30.5, 28.1, 14.4 ppm; IR 
(film): 3019, 2903, 1692, 1642, 1373, 1215, 1115, 751 cm-1; LRMS (EI) m/z: 222.0; 
HRMS (EI) m/z: C12H14O4+ ([M]+), Calc. 222.0892, Found 222.0893. 
 
 
(E)-tert-butyl 5-hydroxy-5-methylhexa-2,3-dienoate (165g) Colorless oil; 92% 
yield; 1H NMR (300 MHz, CDCl3): δ 7.40-7.27 (m, 5H), 6.64 (d, J = 15.8 Hz, 1H), 
6.17 (dd, J = 7.0, 15.8 Hz, 1H), 5.29 (s, 1H), 4.95 (t, J = 7.3 Hz, 1H), 3.35-3.25 (m, 
1H), 3.08-2.95 (m, 1H), 2.37-2.26 (m, 1H), 1.98-1.85 (m, 1H), 1.48 (s, 9H) ppm; 13C 
NMR (75 MHz, CDCl3): δ 174.8, 168.1, 135.9, 132.8, 128.6, 128.1, 127.1, 126.6, 
91.7, 83.5, 79.0, 30.4, 30.1, 28.4 ppm; IR (film): 3019, 2980, 1690, 1638, 1367, 1216, 
1111, 779 cm-1; LRMS (EI) m/z: 286.1; HRMS (EI) m/z: C18H22O3+ ([M]+), Calc. 






(E)-ethyl 2-(1-phenylpiperidin-2-ylidene)acetate (171a) Slight yellow oil; 83% 
yield; 1H NMR (300 MHz, CDCl3): δ 7.41 (t, J = 7.6 Hz, 2H), 7.26 (t, J = 7.6 Hz, 1H), 
7.16 (d, J = 7.3 Hz, 2H), 4.34 (s, 1H), 3.99 (q, J = 7.1 Hz, 2H), 3.47 (t, J = 6.0 Hz, 
2H), 3.24 (t, J = 6.4 Hz, 2H), 1.93-1.78 (m, 4H), 1.15 (t, J = 7.1 Hz, 3H) ppm; 13C 
NMR (75 MHz, CDCl3): δ 167.7, 162.2, 145.1, 128.9, 128.2, 125.8, 85.7, 57.2, 51.0, 
25.3, 22.7, 19.0, 13.6 ppm; IR (film): 3020, 2977, 2896, 1556, 1422, 1216, 1137, 
1046, 929 cm-1; LRMS (ESI) m/z: 268.1; HRMS (ESI) m/z: C15H19O2N123Na1+ 




(E)-tert-butyl 2-(1-phenylpiperidin-2-ylidene)acetate (171b) Slight yellow solid; 
70% yield; 1H NMR (300 MHz, CDCl3): δ 7.40 (t, J = 7.6 Hz, 2H), 7.27-7.22 (m, 1H), 
7.17 (d, J = 7.6 Hz, 2H), 4.32 (s, 1H), 3.44 (t, J = 6.0 Hz, 2H), 3.20 (t, J = 6.4 Hz, 2H), 
1.91-1.76 (m, 4H), 1.38 (s, 9H) ppm; 13C NMR (75 MHz, CDCl3): δ 168.8, 162.2, 
146.4, 130.0, 126.8, 126.5, 89.1, 51.9, 28.6, 27.9, 26.3, 23.8, 20.3 ppm; IR (film): 
3020, 2978, 2897, 1524, 1378, 1216, 1129, 1046, 929 cm-1; mp: 102.5 –103.9 °C; 
LRMS (ESI) m/z: 296.1; HRMS (ESI) m/z: C17H23O2N123Na1+ ([M+Na]+), Calc. 





(E)-tert-butyl 2-(1-(2-tert-butylphenyl)piperidin-2-ylidene)acetate (171c) White 
solid; 70% yield; 1H NMR (300 MHz, CDCl3): δ 7.51-7.48 (m, 1H), 7.28-7.25 (m, 
2H), 7.05 (dd, J = 3.6, 5.6 Hz, 1H), 4.01 (s, 1H), 3.83-3.77 (m, 1H), 3.40-3.30 (m, 2H), 
2.57-2.49 (m, 1H), 1.95-1.59 (m, 4H), 1.36-1.35 (m, 18H) ppm; 13C NMR (75 MHz, 
CDCl3): δ 168.6, 162.8, 146.5, 144.8, 130.1, 128.8, 127.8, 127.6, 91.9, 53.8, 35.5, 
31.2, 28.6, 26.1, 23.6, 20.6 ppm; IR (film): 3020, 2977, 2896, 1524, 1424, 1218, 1129, 
1046, 929 cm-1; mp: 113.5 –114.7 °C; LRMS (ESI) m/z: 352.1; HRMS (ESI) m/z: 






20 mol% TBD used 
(E)-ethyl 2-(6-oxo-1-phenylpiperidin-2-ylidene)acetate (175) White solid; 96% 
yield; 1H NMR (300 MHz, CDCl3): δ 7.52-7.36 (m, 3H), 7.10-7.08 (m, 2H), 4.64 (s, 
1H), 4.05 (q, J = 7.1 Hz, 2H), 3.38 (t, J = 6.4 Hz, 2H), 2.74 (t, J = 6.4 Hz, 2H), 
2.05-1.96 (m, 2H), 1.18 (t, J = 7.1 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 170.5, 
167.2, 157.7, 138.0, 129.9, 128.6, 128.5, 99.6, 59.6, 33.6, 25.8, 18.8, 14.3 ppm; IR 
(film): 3456, 3019, 2977, 2895, 1607, 1215, 1145, 772 cm-1; LRMS (FAB) m/z: 260.0; 
HRMS (FAB) m/z: C15H18O3N1+ ([M+1]+), Calc. 260.1281, Found 260.1286. 
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5.2.6 Procedure for Brønsted-base catalyzed tandem isomerization-aza-Michael 
reaction of alkynyl-carbamate  
 
To a clear and dry vial, tert-butyl 5-(3-fluorophenylcarbamoyloxy)pent-3-ynoate 
177 (46.0mg, 0.15mmol), a stirring bar and anhydrous CH2Cl2 (1.4 mL) were added 
in this sequence. After stirring at room temperature for a while, 
1,5,7-triazabicyclo[4.4.0]dec-1-ene (TBD) (2.1mg, 0.015 mmol) in anhydrous CH2Cl2 
(0.1 mL) were added to the mixture in one portion. After the reaction completed in 3 
hours, the reaction mixture was concentrated and loaded onto a short silica gel column, 
followed by flash chromatography. Product 178 (23.2mg) was obtained as colorless 
oil in 50% yield, product 179 (18.1mg) was obtained in 49% yield which decomposed 
quickly at room temperature 
(E)-tert-butyl 2-(3-(3-fluorophenyl)-2-oxo-1,3-oxazinan-4-ylidene)acetate (178) 
White solid; 50% yield; 1H NMR (300 MHz, CDCl3): δ 7.52-7.45 (m, 1H), 7.20-7.13 
(m, 1H), 6.99-6.93 (m, 2H), 4.60 (s, 1H), 4.44 (t, J = 5.9 Hz, 2H), 3.56 (t, J = 5.6 Hz, 
2H), 1.40 (s, 9H) ppm; 13C NMR (75 MHz, CDCl3): δ 166.0, 164.9, 161.6, 151.9, 
150.6, 138.7 (d, JC-P = 38.7 Hz), 131.2 (d, JC-P = 34.4 Hz), 124.5 (d, JC-P = 12.9 Hz), 
116.3 (d, JC-P = 81.8 Hz), 100.5, 80.4, 64.6, 28.2, 24.6 ppm; IR (film): 3020, 2980, 
1724, 1625, 1140, 735 cm-1; mp: 176.9 – 178.3 °C; LRMS (EI) m/z: 307.1; HRMS (EI) 
m/z: C16H18O4N1F1+ ([M]+), Calc. 307.1220, Found 307.1222. 
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168 97% yield  
To a clear and dry vial, (E)-ethyl 2-(5-phenyldihydrofuran-2(3H)-ylidene)acetate 
165e (7.0mg, 0.03mmol), Pd/C (16.0mg, 0.015mmol), a stirring bar and anhydrous 
MeOH (0.3 mL) were added in this sequence. After stirring at room temperature for a 
while, H2 with a balloom was inserted. After the reaction completed in 43 hours, the 
reaction mixture was directly passed through a pad of celite and washed with MeOH. 
After concentrating, product 168 (6.8mg) was obtained as colorless oil in 97% yield. 
Ethyl 3-oxo-6-phenylhexanoate (168) Colorless oil; 97% yield; 1H NMR (300 MHz, 
CDCl3): δ 7.31-7.26 (m, 2H), 7.19-7.15 (m, 3H), 4.18 (q, J = 7.0 Hz, 2H), 3.40 (s, 2H), 
2.63 (t, J = 7.4 Hz, 2H), 2.55 (t, J = 6.3 Hz, 2H), 1.94 (quintet, J = 7.3 Hz, 2H), 1.26 
(t, J = 7.0 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3): δ 202.6, 167.2, 141.3, 128.4, 
126.0, 61.3, 49.3, 42.1, 34.8, 24.8, 14.1 ppm; IR (film): 3438, 3020, 2977, 2893, 1647, 
1216, 1045, 777 cm-1; LRMS (ESI) m/z: 257.0; HRMS (ESI) m/z: C14H18O323Na1+ 
([M+Na]+), Calc. 257.1148, Found 257.1150. 
 
 
To a clear and dry vial, (E)-ethyl 2-(5-phenyldihydrofuran-2(3H)-ylidene)acetate 
165e (7.0mg, 0.03mmol), a stirring bar and anhydrous CH2Cl2 (0.3 mL) were added in 
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this sequence. After stirring at room temperature for a while, trifluoroborane ether 
complex (11.3μL, 0.09mmol) and triethylsilane (43.0μL, 0.27mmol) were added to 
the mixture in the sequences. After the reaction completed in 5 hours, the reaction 
mixture was concentrated and loaded onto a short silica gel column, followed by flash 
chromatography. Product 169 (6.9mg) was obtained as colorless oil in 98% yield. 
Ethyl 2-(5-phenyltetrahydrofuran-2-yl)acetate (169) Colorless oil; 98% yield (d.r. 
= 5:3); 1H NMR (300 MHz, CDCl3): major δ 7.34-7.32 (m, 4H), 7.27-7.24 (m, 1H), 
4.92 (t, J = 7.1 Hz, 1H), 4.47 (quintet, J = 6.6 Hz, 1H), 4.22-4.14 (m, 2H), 2.82-2.70 
(m, 1H), 2.63-2.51 (m, 1H), 2.38-2.17 (m, 2H), 1.90-1.72 (m, 2H), 1.28 (t, J = 7.1 Hz, 
3H) ppm; minor δ7.34-7.32 (m, 4H), 7.27-7.24 (m, 1H), 5.04 (t, J = 7.2 Hz, 1H), 4.62 
(quintet, J = 6.9 Hz, 1H), 4.22-4.14 (m, 2H), 2.82-2.70 (m, 1H), 2.63-2.51 (m, 1H), 
2.38-2.17 (m, 2H), 1.90-1.72 (m, 2H), 1.28 (t, J = 7.1 Hz, 3H) ppm; 13C NMR (75 
MHz, CDCl3): major δ 171.2, 128.3, 127.2, 125.7, 125.5, 81.2, 75.9, 60.5, 41.1, 34.3, 
31.2, 14.2 ppm; minor δ 171.2, 128.3, 127.1, 125.7, 125.5, 80.4, 75.9, 60.5, 41.1, 35.1, 
32.1, 14.2 ppm; IR (film): 3438, 3020, 2977, 2893, 1647, 1216, 1045, 777 cm-1; 
LRMS (ESI) m/z: 257.0; HRMS (ESI) m/z: C14H18O323Na1+ ([M+Na]+), Calc. 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chiral HPLC Chromatograms 
 
 






















































900 062008 #224 [modified by TCH LAB] LDS10120 UV_VIS_1mAU
min
1 - 28.8872 - 31.180
WVL:210 nm
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1,000 062008 #251 [modified by TCH LAB] LDS10140 UV_VIS_1mAU
min
1 - 10.667

























500 030608 #179 [modified by TCH LAB] LHJ5221A-S UV_VIS_1mAU
min
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